Instytut Hematologii i Transfuzjologii — nowatorskie rozwiązania polegające na kompleksowości, koordynacji, innowacyjności i jakości w celu poprawy diagnostyki i leczenia, komfortu chorego i postępu w medycynie by Warzocha, Krzysztof et al.
173https://journals.viamedica.pl/hematologia
Hematologia
2016, tom 7, nr 3, 173–216
DOI: 10.5603/Hem.2016.0017
Copyright © 2016 Via Medica
ISSN 2081–0768PRACA POGLĄDOWA
Institute of Hematology and Transfusion Medicine — 
a novel approach of combining comprehensiveness, 
coordination, innovation and pro-quality measures  
for improving diagnosis, treatment, patient care,  
and the advancement of medical science
Instytut Hematologii i Transfuzjologii — nowatorskie rozwiązania 
polegające na kompleksowości, koordynacji, innowacyjności  
i jakości w celu poprawy diagnostyki i leczenia,  
komfortu chorego i postępu w medycynie
Krzysztof Warzocha, Przemysław Juszczyński, Ewa Lech-Marańda,  
Magdalena Łętowska, Witold Kmiotek, Beata Lichocka, Piotr Hołownia
Institute of Hematology and Transfusion Medicine, Warsaw, Poland
Abstract
Like in all European countries, Poland has witnessed a continuing rise in healthcare services 
needed for treating hematological disease. Not only have morbidity rates increased in myeloid 
and lymphoid malignancies but, in parallel, a dynamic development of diagnostic methods and 
therapeutic treatments has occurred in recent times. The Institute of Hematology and Transfusion 
Medicine constitutes a reference centre in Poland committed to delivering scientific-clinical excel-
lence where it undertakes scientific studies and translational research in hematology, transfusion 
medicine and related disciplines along with providing healthcare services in such fields. This is 
a modern medical centre focused on coordinating and integrating treatment using new medical 
technologies. A multidisciplinary strategy to medicine ensures that all necessary specialists are 
engaged in disease diagnoses and also for defining disease progression stages together with actual 
treatment, subsequent rehabilitation and follow-up monitoring. By adopting this comprehensive 
approach, optimal therapeutic solutions are thereby achieved; patients receive coordinated medi-
cal healthcare, which above all else, results in faster and more effective treatments. In order to 
achieve such aims, it is vital that all diagnostic and medical units collaborate, including with 
those from other medical centres whenever added specialist treatment is required. In addition to 
standard diagnostics and treatment, the Institute provides highly specialised and innovative treat-
ments that are molecularly targeted, as well as the opportunity of participating in international 
clinical trials, where innovative and experimental therapies are used on patients with myeloid and 
lymphoid malignancies. Such trials have enabled the Institute to apply modern immunological 
and genetic technologies to diagnoses-treatment. Performing such procedures requires a complex 
and multidisciplinary approach, not just for ensuring correct diagnoses, but for also assessing 
prognostic-predictive disease markers, making the diagnoses early, preventing complications,  
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selecting appropriate donor-recipients for hematopoietic cell transplants and evaluating the extent 
of remission. In collaboration with other national centres and those abroad, the Institute is also 
engaged in complex and coordinated programmes devoted to preserving women’s fertility for those 
suffering from cancer and who are treated with chemo/radio-therapy. Over recent years, the Insti-
tute has invested in furnishing individual laboratories with the latest equipment and specialised 
instrumentation. Because of its highly specialist staff, the wide experience of hematopathologists 
and the supporting teams of biologists and biotechnologists, the Institute has at its disposition the 
vital ‘know-how’ thereby allowing developments from scientific studies to become successfully im-
plemented and commercialised. The dynamic rise in this area has driven the creation of innovative 
products under the National Smart Specialisation initiative; this giving the Institute a competitive 
advantage in developing new medical technologies, at both country and international levels.
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Streszczenie
W Polsce, podobnie jak w innych krajach europejskich, obserwuje się ciągły wzrost zapotrzebowa-
nia na świadczenia zdrowotne w zakresie chorób krwi. Na to zjawisko składa się nie tylko obser-
wowana od kilkudziesięciu lat zwiększona zapadalność na nowotwory układów krwiotwórczego  
i chłonnego, ale również dynamiczny rozwój metod diagnostycznych i leczniczych, jaki się dokonał 
w ostatnim czasie. Instytut Hematologii i Transfuzjologii jest referencyjną jednostką naukowo-
-kliniczną prowadzącą badania naukowe i translacyjne w dziedzinie hematologii, transfuzjologii 
i dyscyplin pokrewnych oraz udziela świadczeń medycznych w tym zakresie. Instytut to nowoczesny 
ośrodek krajowy, w którym stawia się na skoordynowane leczenie i nowe technologie medyczne. 
W działalności medycznej personel kieruje się zasadą wielospecjalistycznego podejścia, co oznacza 
udział wszystkich niezbędnych specjalistów na etapie rozpoznawania i określania zaawansowania 
choroby, a także leczenia i prowadzenia rehabilitacji oraz obserwacji po leczeniu. Kompleksowe 
postępowanie zapewnia możliwość uzyskania najlepszych wyników terapii. Skoordynowana opieka 
medyczna, jaką swoim Pacjentom oferuje Instytut, przekłada się przede wszystkim na szybszy i lep-
szy efekt medyczny. Dla osiągnięcia tego celu ważne są interoperacyjność i autentyczna współpraca 
między poszczególnymi jednostkami diagnostycznymi i medycznymi, a także innymi ośrodkami 
prowadzącymi leczenie specjalistyczne. Oprócz standardowych metod diagnostyki i leczenia Insty-
tut oferuje możliwość wysokospecjalistycznego i nowatorskiego leczenia celowanego molekularnie,  
a także uczestnictwo w międzynarodowych badaniach klinicznych z zastosowaniem nowatorskich  
i eksperymentalnych sposobów leczenia chorych na nowotwory układów krwiotwórczego i chłonnego.  
Prowadzone przez Instytut badania naukowe zaowocowały możliwością stosowania nowoczesnych 
technik immunologicznych i genetycznych we wszystkich wymagających takich technologii proce-
sach diagnostyczno-leczniczych. Procesy te są zadaniem złożonym i interdyscyplinarnym; dotyczą 
nie tylko prawidłowego rozpoznania choroby, ale również oceny markerów prognostyczno-predykcyj-
nych, wczesnej diagnostyki i prewencji powikłań, doboru dawców i biorców przeszczepów komórek 
krwiotwórczych, a także oceny głębokości remisji. We współpracy z innymi podmiotami w kraju  
i za granicą Instytut uczestniczy w programie kompleksowego i skoordynowanego zachowania 
rozrodczości u kobiet chorych na nowotwory poddawanych chemio- i radioterapii. Przez ostatnie 
lata Instytut prowadził działania inwestycyjne, które pozwoliły wyposażyć poszczególne pracownie  
w innowacyjną aparaturę i specjalistyczne urządzenia. Dzięki specjalistycznym zasobom kadrowym,  
doświadczeniu hematopatologów oraz wspierającemu ich zespołowi biologów i biotechnologów 
Instytut dysponuje niezbędnym know-how do skutecznego wdrażania i komercjalizacji wyników 
badań naukowych. Dynamiczny rozwój tej dziedziny działalności prowadzi do powstawania inno-
wacyjnych produktów tworzonych w ramach Krajowych Inteligentnych Specjalizacji. Taka sytuacja 
175https://journals.viamedica.pl/hematologia
Krzysztof Warzocha et al., Institute of Hematology and Transfusion Medicine
buduje przewagę konkurencyjną Instytutu w zakresie innowacyjnych technologii medycznych — 
nie tylko na poziomie krajowym, ale też na arenie międzynarodowej.
Słowa kluczowe: hematologia, kompleksowość, koordynacja, innowacyjność jakość, pacjent
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Introduction
The Institute of Hematology and Transfusion 
Medicine became operational under the follow-
ing legislation; Act of 30th April 2010 concerning 
‘Research Institutes’ (Journal of Laws 2016, No. 
371 as amended), Act of 30th April 2010 concer-
ning ‘Provisions for introducing laws reforming 
the education system’ (Journal of Laws 2010, 
No. 620 as amended), Act of 15th April 15th April 
2011 concerning ‘Therapeutic activities’ (Journal 
of Laws 2015, No. 618 as amended), Act of Au-
gust 22nd 1997 concerning ‘Public Blood Service’ 
(Journal of Laws 2014, No. 332 as amended), 
the Council of Ministers Regulation of 2nd June 
1951 ‘On founding the Institute of Hematology’ 
(Journal of Laws 1951, No. 35, item 268) and the 
Ordinance of the Minister of Health and Welfare 
of 28th February 1992 on ‘Changing the name of 
the Institute of Hematology’. The Minister of 
Health bears responsibility for the Institute’s ope - 
ration.
The Institute of Hematology and Transfusion 
Medicine is a state organisation and a legal entity. 
It is registered in the District Court for Warsaw 
Capital City at the XIII Department of Economics at 
the National Court Registry under No. 0000119139, 
as well as in the Registry of Entities Carrying Out 
Medical Activities under the Governor of the Ma-
zovian Region (Registry No: 000000018630). The 
Institute is authorised to use the round seal with 
the emblem of the Republic of Poland positioned in 
the middle with the inscription ‘Institute of Hema-
tology and Transfusion’ around the rim.
The Institute of Hematology and Transfusion 
Medicine is also authorised to award PhD (Doc-
torate) as well as Habilitation degrees and, on the 
basis of separate regulations, professorships.
The executive authorities/ruling body of the 
Institute is the Director and the Science Council. 
The Director manages the Institute with the aid 
of his deputies representing the following areas: 
research, therapeutics, transfusion medicine, ad-
ministration and economics-finance together with 
the Department managers and those holding 
autonomous posts. The Science Council operates 
as an opinion giving and advisory authority/body 
according to the Institute’s statutes, along with 
being responsible for staff development in science 
and technology.
Departmental organisation
In accordance with the 2016 amended statutes 
and regulations governing the Institute of Hema-
tology and Transfusion Medicine, the Therapeu-
tics Division consists of 5 clinics: Hematology, 
Hemostatic Disorders and Internal Medicine, 
Hematopoietic Cell Transplant, General Surgery, 
Oncology, Metabolism and Vascular Surgery. In ad-
dition there are the Anesthesiology and Intensive 
Care Unit, the Operating Theatre and Daily Care 
Unit. These are supported by the Specialist Medi-
cal Clinic, Admissions and the Pharmacy.
The Institute of Hematology and Transfusion 
Medicine also has 8 science departments of re-
search and diagnostic laboratory units comprising 
of Transfusion Medicine, Diagnostic Hematology, 
Hemostatics and Metabolic Disease, Immuno-
logical Hematology and Transfusion Medicine, 
Immunogenetics, Virology, Radiology and Experi-
mental Hematology.
In addition, there are many auxiliary units 
providing support and services intended to uphold 
the operation of the aforementioned departments 
and clinics, consisting of branches, sections, the 
library and autonomous posts (Figure 1).
Staff
The total number of staff are currently 665 per-
sons, that include 88 doctors and 209 nurses. There 
are 43 scientists of whom 9 are full professors (with 
a habilitation degree), 23 are Senior Lecturers and 
5 are Junior Lecturers (Figure 2).
The longest serving staff member was Profes-
sor Koscielak, who was first employed in 1951 as 
a volunteer, after which he became Scientific Secre-
tary and Director of the Biochemistry Department 
for several dozen years. He was then subsequently 
appointed deputy Institute Director for Research 
until his retirement in 2007. Ms Marianne Jonska 
MSc is the longest serving staff member who 
started in 1965 as an accountant, then became 
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Figure 1. Organisational Structure of the Institute of Haematology and Transfusion Medicine
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Chief Accountant Assistant (1985) until she was 
made Chief Accountant and Vice Director for 
Economics-Finances; 2003–2016.
Mission statement
The mission of the Institute of Hematology and 
Transfusion Medicine is to deliver highly specia-
lised healthcare services and undertake research 
and development to further scientific progress in 
the fields of hematology, transfusion medicine and 
associated disciplines; all the while ensuring safe 
and patient-friendly conditions for both patients 
and staff.
From 2008, the Institute is accredited with 
certification for the Integrated Quality Manage-
ment System, Environmental Management and 
Management of Occupational Health and Safety 
according to respectively ISO 9001, ISO 14001 and 
OHSAS 18001 standards. On the 11th May 2015, 
the Minister of Health awarded an accreditation 
certificate to the Institute confirming that all 
operations are directly targeted at patient safety, 
staff and institute visitors, as well as fulfilling 
the requirements of healthcare standards for 
in-patients. Preparing for this accreditation took 
place under the ‘Safe Hospital — Safe Patient’ 
scheme managed by Centre for Quality Control 
and Patient Safety.
For the last 5 years, the Institute of Hemato-
logy and Transfusion Medicine has achieved a very 
high placing in the all-Poland ‘Safe Hospital’ rank-
ings managed by the ‘Rzeczpospolita’ (‘The Re-
public’; one of the main broadsheet newspapers in 
Poland). In 2015, the Institute once again came first 
in the Mazovian province amongst all healthcare 
providers within the region and achieved second 
place throughout Poland in the category of ‘Single 
Specialisation Treatment Hospitals’.
Diagnostics and therapeutics
In 2015, the Institute of Hematology and 
Transfusion Medicine signed 7 contracts with the 
National Health-Funding authority (NFZ) from the 
Mazovian region for providing public health care 
services valued at 123,237,962.18 PLN. This cove-
red 13,583 hospitalisations at the Institute’s cli - 
nics and departments as well as 48,921 out-patient 
consultations, which in all involved performing 
916,707 diagnostic tests.
Within the last years, there has been a con-
tinuous rise in income derived from the statutory 
obligations required of the Institute, above all else 
due to delivering single-specialisation medical 
services, undertaking clinical studies and scientific 
projects including those backed up by grant fund-
ing; both at national and international levels. Such 
funding sources also includes partnerships with 
industry and the private sector, where the focus 
is mainly on specialist studies, assessments and 
in providing expertise. Keeping a healthy financial 
status not only has enabled financial solvency to be 
maintained, with an absence of any binding com-
mitments, but also to have generated a financial 
surplus in 2015. This has allowed the Institute to 
apply for external investment funding, particularly 
from operational programmes funded by the EU 
during 2014–2020. Efforts are now under way 
to obtain funding for a Research and Diagnostics 
Figure 2. The 65th anniversary of the Institute of Hematology and Transfusion Medicine — a group photo of staff
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building at the Ursynow site which can accommo-
date thuse units and departments currently housed 
at the 5 Chocimska Street site.
Research
The outcomes of research performed at the 
Institute of Hematology and Transfusion Medicine 
consist of numerous scientific papers published as 
well as reports and posters presented at scientific 
conferences and congresses; both at home and 
abroad. In the last 5 years, 524 scientific papers 
have been published in journals, with a total im-
pact factor (IF) of 1069 with 2613 citations and 
a Hirsch Index of 19, along with 19 monographs 
in text books and 177 chapters in collective pub-
lications. In addition, 1254 abstracts have been 
published from home and international confe-
rences and congresses consisting of either oral or 
poster presentations. Research project funding 
has also been secured from 12 national grants and 
5 UE ones.
Institute staff actively undertake research 
managed by the Polish Adult Leukemia Group, the 
Polish Group for Lymphoma Research, the Polish 
Myeloma Group and the Polish Hemostasis Group 
as well as being involved on their management 
committees. Together with the Polish Society 
for Hematology and Transfusion Medicine, the 
Institute has been publishing, since 1970, a perio-
dical ‘Acta Haematologica Polonica’, a quarterly 
‘Journal of Transfusion Medicine’ since 2008 (Ed-
itor-In-Chief; M. Letowska) and from 2010 an-
other quarterly ‘Hematologia’ (Editor-In-Chief; 
K. Warzocha). For many years the versatile and 
creative endeavours in science undertaken by 
the Institute’s staff has been rated very highly 
by the ‘Evaluation Committee’ from the Ministry 
of Science and Higher Education, which since its 
inception in 2010, has awarded the institute with 
a Grade A rating.
Teaching
For over many years the Institute’s staff 
have jointly edited journals and monographs for 
diagnostic-therapeutic recommendations for blood 
disease, oncology and transfusion medicine; both 
clinical and laboratory. Amongst others, they have 
been jointly responsible for preparing the follow-
ing: ‘Diagnostic and Therapeutic recommendations 
for cancer’ (eds. M. Krzakowski and K. Warzocha, 
Via Medica, Gdansk 2013), ‘Clinical Oncology’ (eds. 
M. Krzakowski, P. Potemski, K. Warzocha, P. Wysocki, 
Via Medica, Gdansk 2015), ‘Hematologia’ (eds. 
T. Robak and K. Warzocha, Via Medica, Gdansk 
2016) and ‘Medical principles of blood collection, its 
separation and issuing binding instructions to units 
engaged in providing blood services to the public’ 
(ed. M. Letowska, IHT, Warsaw, 2011 and 2014).
An important task of the Institute is to orga-
nise scientific conferences and teaching courses, 
often in association with other centres. For the 
last 10 years the Institute has been the patron of 
an all-Poland conference after the ASH meetings 
(American Society of Hematology); this being 
a review of the most important research studies 
presented at ASH. Furthermore, since 7 years, 
the institute has also been a patron of the national 
conference for the aforementioned ‘Hematalogia’ 
educational journal as well for a cycle of regional 
meetings entitled ‘Hematology and Hemostatics’.
In 2013, a Hematology and Transfusion Medi-
cine Clinic was created, within the institutes struc-
ture, for the Postgraduate Medical Education Centre 
under the directorship of Professor Ewa Lech-Ma-
randa to provide, as the name implies, post-graduate 
education for doctors specialising in hematology and 
clinical transfusion. The institute is also a teaching 
and training centre for doctors specialising in inter-
nal medicine, transplantology and also for laboratory 
diagnosticians specialising in laboratory transfusion 
medicine and medical hematology.
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The tasks of the Hematology Clinic include 
providing diagnostics, treatment and out-patient 
healthcare for patients suffering from diseases of 
the haematopoietic and lymphatic system. The 
clinic consists of: the Diagnostic Hematology 
ward, the Hematopoietic System Disease Ward, 
the Lymphatic System Disease Ward, the Inten-
sive Hematology Care Ward and the Hematology 
Out-Patient Clinic.
The Diagnostic Hematology Ward deals with 
diagnosing neoplastic and non-neoplastic diseases 
of the hematopoietic and lymphatic systems to-
gether with monitoring treatment efficacy. The 
Hematopoietic Diseases Ward and the Lymphatic 
System Disease Ward focus on treating patients 
HEMATOLOGY CLINIC
with cancers of the hematopoietic and lymphatic 
systems, as well as in optimising and implemen-
ting new diagnostic and therapeutic methods. The 
Intensive Hematological Care Ward is devoted to 
treating those patients requiring intensive chemo-
therapy and adjuvant therapy that includes immune 
ablation for bone marrow aplasia and mobilising 
hematopoietic stem cells for transplantation. The 
Hematology Out-Patient Clinic delivers outpatient 
healthcare to those under its care.
Research performed at the clinic consists of 
optimising methods of diagnosis and treating neo-
plastic and non-neoplastic diseases of the hemato-
poietic and lymphatic systems. Such studies are 
undertaken as research projects primarily based on 
the Polish Adult Leukemia Group, the Polish Group 
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at home and abroad. Part of the experimental stu-
dies are carried out in specialised laboratories at 
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The clinic provides teaching courses and 
lectures for physicians specialising in hemato-
logy and organises nationwide conferences under 
the patronage of the institute such as the annual 
post-ASH conferences, the ‘Hematologia’ journal 
conference and holds interactive meetings in 
onco-hematology for the ‘Hematology and Hemo-
statics’ meetings cycle. In collaboration with the 
Clinic of Hematology and Transfusion Medicine 
at the Medical Centre for Postgraduate Studies 
(CMKB), our clinic participates in delivering 
training courses for doctors specialising in clinical 
transfusion medicine, hematology, clinical oncology 
and internal medicine. The clinic possesses the 
accreditation required for training doctors wishing 
to specialise in hematology.
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Tel: +48 22 34 96 483
e-mail: lmichalak@ihit.waw.pl
Lymphatic System Disease Ward
Head: Professor of Medicine 
Christopher Jamroziak MD, DSc
Medical Team: Dr Joanna Barankiewicz, Dr Monica 
Chelstowska, Dr Margaret Jarzembowska, Dr Agnes 
Kolkowska-Lesniak, Dr Agnes Konska, Dr Beatrice 
Kwasniak and Dr Agatha Malenda MD
Secretary’s office: Ms Catherine Zielinska MSc
Tel: +48 22 34 96 483
e-mail: kzielinska@ihit.waw.pl
Intensive Hematology Care Ward
Head: Dr Ilona Seferynska MD
Medical Team: Dr Anna Ejduk, 
and Dr Joanna Sawczuk-Chabin
Secretary’s office: Sylvia Kufera
Tel: +48 22 34 96 472
e-mail: skufera@ihit.waw.pl
Hematology Out-Patient Clinic
Head: Dr Monica Dabrowska
Tel: +48 22 34 96 291; Fax: +48 22 34 96 335
e-mail: hemsek@ihit.waw.pl
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HEMOSTATIC DISORDERS AND INTERNAL MEDICINE CLINIC
Head: Professor of Medicine George Windyga MD, 
DSc
Deputy: Dr Anna Buczma
Senior Lecturers: Dr Bernadette Ceglarek MD 
and Dr Anna Sikorska MD
Doctors: Dr Magdalena Gorska-Kosicka MD, Dr Adel 
Gwozdowska, Dr Slawomir Jurek, Dr Joanna Sowinska 
and Dr Robert Wasilewski MD
Ward nurse: Ms Grazyna Grzesikiewicz-Majewska
Secretary’s office: Ms Marzanna Rasinska MSc 
and Ms Alexandra Wysoczyńska
The clinic’s team delivers diagnoses, treat-
ment and outpatient healthcare to patients suffer-
ing from hemostatic disorders and internal disease, 
particularly in the accompanying hematopoietic or 
lymphatic diseases. Research, consultations and 
teaching are also conducted in these fields.
Therapy is principally focused on treating 
patients with coagulation disorders by, it should 
be emphasised, novel procedures unique in Poland. 
The clinic is also the reference centre in Poland for 
diagnosing and treating patients with hemophilia 
and other inherited and acquired bleeding disorders 
which include rare cases of deficiencies in Factor 
VII, X, XI, XII and afibrynogenemia. Endoprosthe-
sis implantation treatments are coordinated at the 
clinic as well as isotopic synovectomy in patients 
with hemophilic arthropathy. In addition, patients 
are rehabilitated after surgery. A full diagnosis 
of congenital thrombophilia and antiphospholipid 
syndrome are also undertaken at the clinic together 
with full diagnoses and treatment of exacerbated 
acute intermittent porphyria; all patients with 
porphyria receiving appropriate healthcare.
Research at the clinic deals mainly with he-
mostatic disorders. A central registry of patients is 
kept in our clinic for those suffering from congenital 
bleeding disorders from around the whole country 
as well as patients affected by thrombophilia. This 
includes patients with genetic defects that make 
them especially vulnerable to thrombosis, ie. defi-
ciencies in antithrombin, protein C or protein S and 
hetero-homozygous status in factor V Leiden gene 
mutation or prothrombin G20210A gene mutation 
as well as other associated gene defects. The clinic 
collaborates with centres from abroad and others 
in Poland, performing research on the underly-
ing genetics of congenital bleeding disorders and 
on the etiology of venous thromboembolism and 
ischemic stroke when occurring at a young age. 
Individual-based training for doctors specialising in 
hematology and internal medicine is also conducted 
by our clinic.
The clinic is divided as follows: Hemostatic 
Disorders Ward, Internal Medicine and Geriatrics 
Ward, Physiotherapy Clinic, Hemostatic Disor-
ders Clinic and a Out-Patient Clinic for porphyria 
patients and their families.
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 158, +48 22 34 96 481 
e-mail: sekretariatkzh@ihit.waw.pl
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HEMATOPOETIC CELL TRANSPLANT CLINIC
Head: Dr Casimir Halaburda MD
Deputy: Dr Agnes Tomaszewska MD
Senior Lecturer: 
Dr Barbara Nasilowska-Adamska MD
Junior Lecturer: 
Dr Andrew Szczepinski MD
Ward nurse: Ms Margaret Kacprzak
Secretary’s office: Ms Ilona Lesiak
The clinical team performs hematopoietic stem 
cell transplantation; either the patient’s own or ones 
collected from donors derived from the family or 
unrelated persons. The clinic has a transplantation 
ward comprising 15 separate patient units equipped 
with air and overpressure filters. At the clinic, 
a highly qualified and experienced team of physicians 
and nurses are responsible for delivering healthcare 
to patients undergoing transplantation. After this 
operation, patients previously treated at the Insti-
tute continue to receive care at the post-transplan-
tation clinic. Those that were referred from other 
hematology centres, are sent back there to continue 
on with their treatment/care.
The clinic is accredited by the Ministry of 
Health and the European Society for Blood and 
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 360, +48 22 34 96 361 
e-mail: transplantacja@ihit.waw.pl
Marrow Transplantation for collecting and trans-
planting hematopoietic cells. It also has accredita-
tion that allows training of those doctors wishing 
to specialise in clinical and hematological trans-
plantology.
The research interests of the clinic are on 
optimising molecular methods that assess hema-
topoietic chimerism in the leucocyte fraction of 
the circulating blood in allogeneic hematopoietic 
cells recipients. We also assess the impact of ABO 
incompatibilities between donor and recipients on 
outcomes of allogeneic transplantation along with 
investigating immuno-hemolytic complications 
occurring in such patients. Our research also in-
cludes monitoring respiratory system function in 
patients before and after allogeneic transplantation 
for early detection of complications associated 
with transplantation, that includes bronchiolitis 
obliterans. Another important area of research is to 
determine the relevance of molecular and genetic 
factors affecting clinical outcomes in patients with 
acute myeloid leukemia.
Our clinic also consists of a Clinical Ward and 
a Post-Transplantation Out-Patient Clinic.
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GENERAL SURGERY, ONCOLOGY AND METABOLISM CLINIC
Head of Clinic: Professor of Medicine  
Andrew Szczepanik MD, DSc
Head of General Surgery Ward: Dr Wojciech  
Jaskowiak MD
Head of Surgical Oncology and Metabolism Ward: 
Dr Conrad Pielacinski MD
Doctors: Professor of Medicine Mark Dedecjus MD, 
DSc, Dr Slawomir Huszcza MD, Dr Andrew Misiak MD, 
Dr Wojciech Dabrowski, Dr Slawomir Gajda and Dr Mi-
chael Kurylowicz
Ward nurse: Ms Agnes Cholewa-Zietek MSc
Secretary’s office: Ms Monica Mendza 
and Ms Eva Zbiciak
The tasks of the Clinic team are diagnosis, 
surgical treatment and outpatient health care over 
patients undergoing general surgery, especially 
when accompanied with disorders of hemostatics 
and the hematopoietic and lymphatic systems. The 
clinic also conducts research as well as providing 
training and consultations in these aforementioned 
areas.
Surgical treatment of patients with congenital 
and acquired disorders of coagulation constitutes 
the main therapeutic area of the clinic. Full scale 
operations are carried out on patients suffer-
ing from the entire range of onco-hematological 
disease, that include splenectomy, using classical 
and laparoscopic methods. Other operations un-
dertaken are those regarding abdominal surgery in 
cases of cancer and non-cancer disease employing 
again, classical and laparoscopic methods.
Areas of research are focused on surgery; 
general, cancer and metabolism. Also included is 
surgery applied to treating patients with congenital 
hemostatic disorders and portal hypertension along 
with either preventing the chronic disease thrombo-
embolism from arising or in its treatment. Our clinic 
team performs studies on the diagnostics and treat-
ment of chronic bleeding from the gastrointestinal 
tract in patients with hemophilia, von-Willebrand 
disease, and the use of recombinant activated fac-
tor VII for life-threatening bleeding in haemophiliac 
patients with high levels of factor VIII inhibitor. The 
clinic also conducts tests on the suitability of per-
forming splenectomy in a variety of hematological 
and non-hematological diseases, particularly focus-
ing on optimising laparoscopic techniques for excis-
ing this organ. Treating non-healing trophic ulcers 
at various locations is another study area, where 
silica-gel plates are used to test treatment efficacy. 
Many centres in Poland collaborate with our clinic, 
chiefly in training courses regarding hemostatic 
disorders, surgery and anesthesia.
Our clinic consists of: a General Surgical 
Ward, a Surgical Oncology and Metabolic Ward, an 
Endoscopic Unit and a Surgery Out-Patient Clinic.
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 271, +48 22 34 96 470 
e-mail: chirurg@ihit.waw.pl
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VASCULAR SURGERY CLINIC
Head: Professor of Medicine Peter Szopinski MD, 
DSc
Deputy: Dr Jack Michalak MD
Head of Surgical Radiology: Dr Jaroslaw Ivanovo MD
Senior Lecturer: Dr Eliza Pleban MD
Junior Lecturer: Dr Adam Wiszniewski MD
Doctors: Dr Martin Janas MD, Dr Radoslaw Bilski, 
Dr Martin Sitarz, Dr Thomas Dobrowolski 
and Dr Matthew Stryga
Ward nurse: Ms Ida Kacprzak MSc
Secretary’s office: Ms Joanna Kurzynska MSc 
and Ms Victoria Kowalska MSc
Our clinic started operating in 2009 and pro-
vides diagnosis, treatment and outpatient care for 
vascular surgery patients, as well as consultations 
within this field. Surgery is performed using all 
techniques used in vascular surgery that include 
both classical and the latest intravascular ones; 
this amounts to 1200 operations annually includ-
ing about 80 aortic stent-graft implantations. In 
March 2012, one of the most up-to date hybrid 
operating rooms in Europe was opened at our clinic 
which enabled the range of hybrid operations to 
be extended on the thoracic and abdominal aorta, 
where surgical techniques are coupled with stent 
implantation, stent grafting and venous stent im-
plantation.
Research is devoted to evaluating treatment 
outcomes for patients with aneurysms of the tho-
racic aorta through using abdominal stent grafting, 
using bio-prostheses in patients with infection or 
with a high infection risk of the vascular bridge 
and evaluating long-term outcomes of angioplasty 
to leg arteries using a balloon catheter coated with 
paclitaxel in patients with diabetes.
The Clinic team also provides scientific teach-
ing in collaboration with other scientific research 
and clinical centres in both Poland and abroad. We 
organise individual training and regular workshops 
on vascular surgery to physicians from Poland and 
abroad as well as for nurses.
The clinic is comprised of: a Vascular Surgery 
Ward, Surgical Radiology Unit and a Vascular Sur-
gery Out-Patient Clinic.
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 479 
Fax: +48 22 34 96 110 
e-mail: vascular@ihit.waw.pl
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ANESTHESIOLOGY AND INTENSIVE CARE UNIT
Head: Dr Christopher Przybylski MD
Deputy: Dr Alina Ostas
Doctors: Dr Adam Grabowski, Dr Christopher Juszko, 
Dr Catherine Krysztopik, Dr Christopher Panek,  
Dr Monica Pytlewska and Dr Christopher Rusiniak MD
Ward nurse: Ms Barbara Wojcik MSc
Secretary’s office: Ms Eleanor Marszal
Our department delivers anesthesiology 
healthcare for those patients undergoing surgery 
and for all patients facing direct threats to their 
lives or those needing monitoring and basic life 
support. Another task is to provide round the 
clock intensive care and consultation services at 
the institute. We perform anesthesia for patients 
requiring surgical operations because of coagu-
lation disorders, those that are at high risk and 
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 474 and +48 22 34 96 409 
Fax: +48 22 34 96 462 
e-mail: emarszal@ihit.waw.pl
complex cases of vascular surgery, which include 
intravascular procedures. Post-operative care is 
also directly given to all surgical patients. The de-
partment is responsible for ensuring intravenous 
access in patients being treated with chemotherapy 
or having undergone hematopoietic stem cell trans-
plantation, as well as other procedures requiring 
specialised intravenous cannuli to be inserted. In 
addition, appropriate conditions have been created 
for conducting renal replacement therapy, plasma-
pheresis and the ability for stimulating the heart by 
external or by endocardial means. The Department 
team also treats pain, particularly when associated 
with cancer.
The Departments of Anesthesiology and that 
of Intensive care make up this Unit.
191https://journals.viamedica.pl/hematologia
Krzysztof Warzocha et al., Institute of Hematology and Transfusion Medicine
Head: Dr Alina Ostas
Ward nurse: Ms Elizabeth Sosnowska
The operating theatre deals with all organisa-
tional aspects of surgery performed at the insti-
tute. It consists of three air-conditioned operating 
theatres equipped with laminar air flow filters 
and a recovery room. Undertaken operations are 
from the Clinic for General Surgery, Oncology and 
Metabolism along with Vascular Surgery Clinic. 
A hybrid operating room was recently opened in 
2012 which extended the range of surgical opera-
OPERATING THEATRE
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 426 
e-mail: emarszal@ihit.waw.pl
tions and treatments linking intra- and extra-vas-
cular surgery with stent implantation or grafting, 
that includes the thoracic and abdominal aorta as 
well as the venous system.
Head: Dr Thomas Szpila
Doctor: Dr Bernadette Ceglarek MD
Ward nurse: Ms Yvonne Redel
Nursing team: Ms Magdalena Janisz, Ms Maria  
Piotrowska, Ms Elizabeth Mirek, Ms Grazyna  
Wojciechowska, Ms Dorothy Zembek, Mr Stanley Sas 
and Ms Beatrice Wisniewska
Orderlies: Ms Barbara Chmielewska and Ms Bozena 
Nowak
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 146, +48 22 34 96 147
e-mail: izba@ihit.waw.pl
ADMISSIONS
PHARMACY
Head: Ms Ursula Szustkiewicz MSc
Address: 5 Chocimska Street, 00–791 Warsaw
Tel: +48 22 34 96 612
Fax: +48 22 34 96 613
e-mail: apteka@ihit.waw.pl
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Head: Dr Joanna Wlodarska MD
Doctor: Dr Thomas Szpila
Secretary’s office: Ms Margaret Olejniczak
DAILY CARE UNIT
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 150 
Fax: +48 22 34 96 492 
e-mail: old@ihit.waw.pl
Address: 5 Chocimska Street, 00–791 Warsaw 
Tel: +48 22 34 96 628 
Fax: +48 22 34 96 619 
e-mail: apteka@ihit.waw.pl
Treatment delivered by this department is 
conducted at both institute sites, (ie. at 14 Indira 
Gandhi Street and 5 Chocimska Street), under 
those procedures applying to outpatients. Patients 
are also admitted from clinics at the Institute of 
Hematology and Transfusion Medicine as well as 
the Hematology Clinic for providing them with 
chemotherapy treatment. Another procedure un-
dertaken by the department is support treatment 
with bisphosphonates and gamma globulin substi-
tution. Furthermore, therapeutic phlebotomies and 
intravenous iron supplementation are carried out.
Doctor of Epidemiology
Martha Wroblewska MD, DSc
Epidemiological nurse: Ms Margaret Giemza MSc
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel/Fax: +48 22 34 96 245
e-mail: mgiemza@ihit.waw.pl
EPIDEMIOLOGIST AND EPIDEMIOLOGY NURSE
CLINICAL PSYCHOLOGY
Ms Margaret Piatek MSc
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96472
e-mail: mpiatek@ihit.waw.pl
Ms Kinga Bystrek MSc
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 333
Head: Dr Joanna Wlodarska MD
Secretary’s office: Ms Martina Piatkowska and Ms 
Evelina Glowacka
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Head of Clinic: Dr Elizabeth Madro MD
Doctors: Dr Izabela Kopec MD, Dr Agnes Luczak, Dr Eva 
Mendek-Czajkowska MD, Dr Thomas Russjan, Dr Eva 
Stefanska-Windyga and Dr Hanna Wroblewska-Kozak
Consultant: Professor of Medicine Stanley Maj MD, 
DSc
Registration manager: Ms Dagmara Malczyk
The clinic provides outpatient advice and 
consultation concerning the hematopoietic and 
lymphatic systems together with running diagnos-
tics within diagnostic data and treatment. It also 
performs diagnostics and treatment of bleeding 
disorders as well as for pregnant women suf-
fering from hematological disorders, whenever 
serological incompatibilities arise and for hema-
tological cases of recurrent reproductive failure. 
Another task of the clinic is to qualify and steer 
patients for treatment to the Hematology Clinic, 
to Daily Care Unit, to the Hemostatic Disorders 
and Internal Medicine Clinic or to primary health 
care units. The clinic team is also responsible for 
the healthcare testing of institute staff upon their 
starting employment and periodically thereafter.
SPECIALIST OUT-PATIENT CLINIC
Within the Specialist Out-Patient Clinic are 
the following departmental clinics: Blood Disease 
Clinic, Coagulation Disorders Clinic, Hematology 
Clinic for Pregnant Women, Congenital Anemic 
Disorders Clinic and Occupational Health Clinic.
Blood Disease Clinic
Head: Dr Elizabeth Madro MD
Doctors: Dr Agnes Luczak and Dr Thomas Russjan
Address: 5 Chocimska Street, 00-791 Warsaw, 
Building A, first floor
Tel: +48 22 34 96 609 and +48 22 34 96 653
Fax: +48 22 34 96 619
Hematology Clinic for Pregnant Women
Head: Dr Isabella Kopec MD
Address: 5 Chocimska Street, 00–791 Warsaw, 
Building A, first floor
Tel: +48 22 34 96 609 and +48 22 34 96 653
Fax: +48 22 34 96 619
Coagulation Disorders Clinic
Head: Dr Eva Stefanska-Windyga
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 100 and +48 22 34 96 132
Congenital Anemic Disorders Clinic
Head: Dr Eva Mendek-Czajkowska MD
Address: 14 Indira Gandhi Street, 02-776 Warsaw, 
Block A, ground floor (Specialist Outpatients)
Tel: +48 22 34 96 129
Fax: +48 22 34 96 459
Occupational Health Clinic
Doctor: Dr Hanna Wroblewska-Kozak
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 34 96 00 ext. 129, 131, 132 and 297
Fax: +48 22 34 96 459
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 609 and +48 22 34 96 653 
Fax: +48 22 34 96 619
Address: 5 Chocimska Street, 00–791 Warsaw 
Tel: +48 22 34 96 600, ext. 129, 131, 132 and 297 
Fax: +48 22 34 96 459 
e-mail: przychodnia@ihit.waw.pl
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Head: Professor of Medicine Magdalena Letowska 
MD, DSc
Deputy: Doctor of Pharmacology Elizabeth Lachert PhD
Professors: Professor of Medicine Richard Poglod 
MD, DSc
Senior Lecturers: Doctor of Pharmacology Jolanta 
Antoniewicz-Papis PhD, Doctor of Pharmacology Eliza-
beth Lachert PhD and Dr Alexander Rosiek MD
Junior Lecturer: Doctor of Pharmacology Jolanta 
Kubis PhD
Doctors: Dr Lech Rzymkiewicz and Dr Monica Grze-
gorek
Nurses: Ms Beatrice Wisniewska MSc, Ms Eva Pie-
trowiak MSc, Ms Milena Prusaczyk MSc, Ms Yvonne 
Dziarnowska, Ms Bozena Knyt, Ms Monica Matusz, 
Ms Eva Szczepanska, Ms Marzena Wojcik and Ms Eli-
zabeth Zawirska
Laboratory diagnosticians: Ms Anna Kuziak MSc, 
Ms Ewa Mik MSc, Ms Caroline Pienko MSc, Ms Eva 
Potocka MSc and Ms Anna Tomaszewska MSc
Junior assistants: Mr Artur Ejduk MSc, Mr Thomas 
Jankowski MSc, Ms Martha Gawrys MSc and Ms Aga-
tha Plodzich
Technicians: Ms Margaret Pawlik (Senior technician), 
Ms Bozena Wasilewska (Senior technician) and Ms Eli- 
zabeth Wisniakowska (Senior technician)
Laboratory assistants: Ms Elizabeth Kepka and Ms Ma- 
rzena Klokocka
Secretary’s office: Ms Caroline Milewska MSc, Ms Eli- 
zabeth Kowalczyk and Ms Janet Mioduszewska
English Philologist: Ms Christine Dudziak MSc
Senior Clerks: Ms Aleksandra Czajkowska MSc 
and Ms Martina Romanesque-Pluzanska MSc
Medical Admissions Clerks: Ms Elizabeth Frankowska 
and Mr Sigismund Karasinski
Senior IT Inspectors: Mr Christopher Sutkowski BEng 
and Mr Paul Klobukowski
DEPARTMENT OF TRANSFUSION MEDICINE
The department undertakes scientific research 
and provides medical services in the fields of 
transfusion medicine and microbiology, along with 
teaching and consultation services within this re-
mit. Our team also manages the National Registry 
for Blood Donors of blood, the Bone Marrow Donor 
Centre and the Stem Cell and Blood Banks. It is 
responsible for ensuring the safety of blood treat-
ment components and products at the institute.
Under its legal obligations, the department 
fulfils its statutory duties in the Public Blood Ser-
vice insomuch as it has full supervision over those 
public service units so responsible. The depart-
ment publishes regulations on how blood should 
be taken from patients, how blood is separated into 
components for being dispensed, and carries out 
checks at Blood Donation Centres (CKiK). Tasks 
also include supervising quality control over blood 
products obtained at the CKiKs together with being 
responsible for their registration and for their re-
lease (plasma derived concentrates of coagulation 
factors and anti-D immunoglobulin). Moreover, in 
collaboration with the Ministry of Health and the 
National Blood Centre (NCK), the department is 
involved in legislative work governing blood dona-
tion and transfusion; it also takes part in European 
Community projects in these fields.
At our department, centres for taking blood, 
bone marrow donation and laboratories for prepa-
ring hematopoietic stem cells (HSCs) operate in 
accordance with Act on Transplantation of Tissues 
and Organs. The services delivered by the depart-
ment thereby consist of: harvesting HSCs (both 
from bone marrow and peripheral blood), prepa-
ring them for transplantation and preparing blood 
samples from the umbilical cord. We also manage 
the Bone Marrow Donation Centre in collabora-
tion with other institutes departments. Besides 
preparing ‘artificial tears’ from autologous serum 
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 371 
Fax: +48 22 34 96 372 
e-mail: bloodorg@ihit.waw.pl
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for treating patients with dry eye syndrome, which 
some suffer from when undergoing ‘Graft versus 
Host Disease’ (GvHD), we prepare the basic 
components of autologous fibrin glue and plate 
gels. Thanks to having modern equipment, the de-
partment is able to undertake specialised research 
in blood donation and transfusion.
Scientific studies are focused on issues when 
blood is used in treatment (including complica-
tions of transfusing blood components; not only in 
the Institute but also in the whole of Poland), as 
well as methods of collection, processing, storage, 
transport and the quality control of blood and its 
components. Research is undertaken in methods of 
preparing HSCs for transplantation purposes. Our 
team is also clinically evaluating the therapeutic 
uses and hemostatic properties of autologous and 
allogeneic fibrin glue preparations and plate gels. In 
addition, work is being done on assessing the quality 
and safety of enriched blood components stored in 
solutions, the effect of irradiation and inactivation 
and other newly introduced blood procedures. Our 
department closely collaborates with both the De-
partments of Virology and Immunological Hemato-
logy and Transfusion Medicine regarding blood dona-
tion and hemotherapy as well as the Department of 
Immunogenetics on HSC donor issues.
In terms of teaching, our department provides 
staff training and organises courses in blood trans-
fusion especially for those units engaged in public 
blood health services and for laboratory diagnos-
ticians specialising within laboratory transfusion 
medicine. In collaboration with the Hematology 
and Transfusion Medicine Clinic at the Centre for 
Postgraduate Education (CMKP), our staff take 
part in courses for doctors specialising in clinical 
transfusion medicine, hematology, clinical onco-
logy and internal medicine. The department also 
conducts training on an individual basis.
The following are sub-divisions of the depart-
ment: the Laboratory of Clinical Blood Transfusion 
including the Blood Bank, the Laboratory of Trans-
fusion Medicine including the Hematopoietic Cell 
Bank, Quality Assurance Laboratory, Blood Service 
Organisation Unit, Microbiology Laboratory and 
the Centre for Bone Marrow Donation.
Laboratory of Transfusion Medicine including the Hematopoietic Cell Bank
Head: Doctor of Pharmacology Jolanta Antoniewicz- 
-Papis PhD
Team: Ms Martha Gawrys MSc, Ms Caroline Pienko 
MSc and Ms Margaret Pawlik (Senior technician)
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 381, +48 22 34 96 388 and 
+48 22 34 96 389
e-mail: ptlzbkk@ihit.waw.pl
Within the laboratory, a Hematopoietic Cell 
Bank operates that deals with testing, processing 
(preparatory procedures and cryopreservation), 
storage and dispensing HSCs from the bone mar-
row and peripheral blood as well as allogeneic 
umbilical cord blood. The Bank has a class A clean-
liness rating.
The laboratory is accredited by the Ministry 
of Health for the acquisition, processing and stor-
age of HSCs awarded for meeting the set legal 
and quality requirements according to the law on 
the collection, storage and transplantation of cells, 
tissues and organs.
Specialist autologous formulations are pre-
pared in the laboratory and used, amongst other 
things, for treating the ‘dry eye syndrome’ (by 
means of ‘artificial tears’) and treating hemolytic 
disease in the foetus/newborn whenever blood 
incompatibilities occur with the mother (concen-
trates of platelets and erythrocytes).
Our laboratory staff take part in training at the 
Department on blood donation, hemotherapy and 
HSC banking intended for transplantation. Many 
studies have been published in scientific journals 
and our staff participate in surveillance over Public 
Blood Service Units.
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Laboratory of Clinical Blood Transfusion including the Blood Bank
Head: Professor of Medicine Richard Poglod MD, DSc
Team: Dr Lech Rzymkiewicz, Ms Beatrice Wisniewska 
MSc (Ward), Ms Eva Pietrowiak MSc and Ms Milena 
Prusaczyk MSc, Ms Yvonne Dziarnowska, Ms Bozena 
Knyt, Ms Monica Matusz, Ms Eva Szczepańska,  
Ms Marzena Wojcik and Ms Elizabeth Zawirska
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 556, +48 22 34 96 533 and 
+48 22 34 96 569
e-mail: rpoglod@ihit.waw.pl
The laboratory performs plasmapheresis, 
thrombocyte-apheresis and leukapheresis treat-
ments. It is also a centre for extracting HSC from 
the circulation provided by unrelated donors and it 
collaborates with other bone marrow donor cen-
tres. The laboratory uses autologous blood and its 
components to formulate specialist products as well 
as catering for patient blood and blood component 
needs for all clinics and departments at the institute. 
We also give consultations on hemotherapy matters 
and for blood components and products.
Centre for Bone Marrow Donation
Head: Doctor of Medicine Monica Grzegorek
Team: Ms Aleksandra Czajkowska MSc, Mr Thomas 
Jankowski MSc and Ms Martina Romanesque-Pluzanska
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 375, +48 22 34 96 376, +48 22 34 96 380, 
+48 22 34 96 390 and +48 22 34 96 391
e-mail: ods@ihit.waw.pl
Our centre conducts teaching and provides 
information for promoting HSC donation from 
unrelated persons. HSC donor recruitment and 
their investigation are undertaken and the centre 
takes part in their final qualification, where it is 
responsible for coordinating donor healthcare 
after donation. It also takes part in recruitment 
campaigns for potential bone marrow donors.
Quality Assurance Laboratory
Head: Doctor of Pharmacology Elizabeth Lachert
Team: Doctor of Pharmacology Jolanta Kubis PhD 
(Specialist in laboratory transfusion medicine), Ms Ewa 
Potocka MSc, Ms Agata Plodzich (Senior technician), 
Ms Elizabeth Wisniakowska, Ms Marzena Klokocka and 
Ms Elizabeth Kowalczyk
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 382, +48 22 34 96 386 and 
+48 22 34 96 387
e-mail: bloodorg2@ihit.waw.pl
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Inspections of blood component quality are 
carried out at the laboratory from public blood 
service units and initial batch testing is done on 
blood derived products.
The laboratory oversees the public blood 
service organisational units as well as on vali-
dating the storage of blood and its components 
together with refrigerated reagents and test sam- 
ples. It also performs quality control of blood 
components stored at the institute’s blood bank 
and analyses the documentation regarding blood 
derived products according to OCABR control 
procedures.
As part of its delivered services, the labora-
tory assesses equipment and disposable devices 
in terms of their usefulness to CKiKs along with 
preparing autologous concentrates of fibrinogen 
and plate gels.
Research is conducted on preparative procedures 
and storage conditions for blood and its components 
as well as optimising methods for obtaining both 
autologous fibrinogen concentrates and plate gels.
The laboratory organises courses for labora-
tory diagnosticians taking exams on laboratory 
transfusion medicine and also trains staff from the 
Department of Transfusion Medicine.
Blood Service Organisation Unit
Head: Ms Anna Tomaszewska MSc
Team: Dr Alexandra Rosiek MD, Ms Christine Dudziak 
MSc, Mr Christopher Sutkowski (Engr) and Mr Paul 
Klobukowski
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 377, +48 22 34 96 379, +48 22 34 96 384, 
+48 22 34 96 401 and +48 22 34 96 482
e-mail: antomaszewska@ihit.waw.pl
The laboratory undertakes an organisational 
and professional role according to the tasks set out 
in the Act on Public Blood Service. This consists 
of managing the National Register of Blood Donors 
and analysing reported reactions when transfusing 
blood components and any adverse events. Other 
tasks include preparing an annual report for the 
EDQM OMCL Network on the basis of initial batch 
testing controls.
Microbiology Laboratory
Head: Ms Eva Mik MSc
Team: Ms Anna Kuziak MSc (microbiology in medicine 
specialist), Ms Bozena Wasilewska (Senior technician) 
and Ms Elizabeth Kepka
Address: 5 Chocimska Street, 02–776 Warsaw
Tel: +48 22 34 96 616 and +48 22 34 96 641
e-mail: emik@ihit.waw.pl
Our Laboratory performs bacteriological and 
mycological diagnostics for the clinics and depart-
ments of the Institute and for outside bodies. Auto-
mated analysers are used for these purposes, (the 
microbial VITEK 2 Compact), which provides ac-
curate and reproducible measurements. Culturing 
blood and other body fluids are performed on the 
automated Bactec 9050 and BactAlert systems, allow-
ing a rapid evaluation of blood samples, when positive, 
which enables such results to be rapidly relayed to 
clinicians to which therapy can be suitably directed. 
Results of laboratory tests that prove positive and any 
alert pathogens detected are sent to the Nosocomial 
Control Team and to the Institute departments. The 
laboratory also prepares and presents the current 
microbiological status and trends in rising bacterial 
resistance. It regularly participates in external qua-
lity control, ‘Polmicro’, and possesses accreditation 
certificates for microbiology testing.
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The Laboratory performs microbiological 
testing on all clinical materials: ie. blood, body 
fluids, pus, sputum, urine, feces and swabs from 
the throat, nose and eyes. This covers the follow-
ing functions:
1) Identification:
• Gram-negative bacteria from Entero-
bacteriaceae family and non-fermenting 
bacilli species,
• B-hemolytic streptococci groups A, B, C, 
D, F, G, pneumococci and enterococci,
• Haemophilus bacilli,
• Diplococci inflammation of the meninges,
• Anaerobic microorganisms.
2) Differentiating coagulase-negative and coa-
gulase-positive staphylococci for identifying 
staphylococci species isolated from blood and 
body fluids.
3) Determining the sensitivity of isolated micro-
organisms to antibiotics and chemotherapy as 
recommended by EUCAST and the National 
Reference Centre for Microbial Methods Sus-
ceptibility using: diffusion discs, the automat-
ed VITEK system and the E-test (measuring 
minimum inhibitory concentrations).
4) Elucidating the mechanisms of resistance:
• methicillin-resistant staphylococci,
• glycopeptides resistant staphylococci and 
enterococci,
• ESBL production by Gram-negative ba-
cilli,
• cAMP production by Gram-negative bacilli,
• MBL production by Gram-negative bacilli,
• KPC production Gram-negative bacilli,
• OXA-48 production by Gram-negative ba-
cilli.
DEPARTMENT OF DIAGNOSTIC HEMATOLOGY
Head: Professor of Medicine Monica Prochorec-So-
bieszek MD, DSc
Senior Lecturers: Dr Ursula Podstawka MD, Dr Anna 
Szumera-Cieckiewicz MD and Dr Patrick Gorniak
Doctors: Dr Olga Szymanska-Giemza
Laboratory diagnosticians: Doctor of Biology Ursula 
Bany-Laszewicz PhD, Dr Catherine Borg MD, Dr Yvonne 
Solarska MD, Dre Jolanta Wozniak MD, Ms Agnes 
Gajewska MSc, Ms Danuta Gwozdz MSc, Ms Barbara 
Kruk MSc, Ms Agnes Krzywdzinska MSc, Ms Evelina 
Franecka MSc, Ms Hanna Weasel-Makuch MSc, Ms Eva 
Migal MSc and Ms Grayna Nowak MSc
Biologists: Ms Alexandra Bluszcz MSc (Engr.), Ms Edith 
Derezinska MSc, Ms Bozena Rawska MSc and Doctor 
of Biolog. Magdalena Wojtas
Technicians: Ms Barbara Bielecka (Senior technician), 
Ms Agatha Bielinska (Engr), Ms Yvonne Kania (Engr), 
Ms Renata Miąsko, MSc (Engr), Ms Monica Okla (Senior 
technician), Mr Robert Zietek (Senior technician) and 
Ms Halina Wicher (Senior technician)
Secretary’s office: Ms Yvonne Sosnowska
Consultant: Professor of Medicine Maria Kraj MD, DSc
Scientific research and healthcare services 
are conducted within this department on the 
pathogenesis and diagnosis of hematopoietic and 
lymphatic system diseases as well as teaching 
and consultation in these areas. The department 
performs comprehensive and multidisciplinary 
diagnostics and monitoring of patients treated for 
diseases of the hematopoietic and lymphatic sys-
tems according to guidelines and national standards 
from international scientific societies, working 
groups, the World Health Organization and the 
European LeukemiaNet. Diagnostic tasks for the 
Department are carried out in close collaboration 
with other departmental laboratories and institute 
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 296 and +48 22 34 96 495 
Fax: +48 22 34 96 494 
e-mail: diaghem@ihit.waw.pl
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clinics; tests include cytological, cytochemical and 
cytoenzymatic ones as well as measuring cytofluo-
rometric, and molecular cytogenetic markers. Also 
residual disease testing for leukemias and lym-
phomas are undertaken using flow cytometry and 
molecular methods.
Research at the department is concerned 
with its diagnostic-service activities on optimising 
methods of patient diagnoses and in monitoring 
treatment efficacy for those suffering from can-
cer to the hematopoietic and lymphatic systems 
as well as investigating the mechanisms of their 
pathogenesis and identifying rational therapeutic 
targets for such diseases. Other tasks include the 
banking and archiving of tissues and cells along 
with isolated biological material for research. The 
department closely collaborates in studies with 
clinics and departments of the Institute and with 
the Department of Experimental Hematology.
Our department consists of: the Analytical 
Medical Laboratory, an Immunophenotyping, 
laboratory, a Cytogenetics Laboratory, a Labo-
ratory of Molecular Biology and a Laboratory 
of Pathology.
Analytical Medical Laboratory
Head: Ms Eva Migal MSc
Team: Ms Danuta Gwozdz MSc (laboratory diagnosti-
cian), Dr Barbara Kruk MD (laboratory diagnostician), 
Ms Eliza Zaremba MSc (specialist in medical laboratory 
diagnostics), Ms Barbara Bielecka (Senior Technician in 
medical analysis) and Ms Halina Wicher (Senior techni-
cian in medical analysis)
The Laboratory carries out hematological 
disease testing of hematopoietic and lymphatic 
systems that include:
• Cyto-morphological assessment of peripheral 
blood smears and bone marrow.
• Measurement of alkaline phosphatase activity 
in granulocytes and the circulation (periphe-
ral blood).
• Measurement of the activity of tartarated resis - 
tant acid phosphatase.
• Measurement of nonspecific esterase activity.
• Measurement of peroxidase activity.
• Sudan-Black B staining.
• Periodic Acid Schiff (PAS) reaction.
• Detecting sideroblasts ringed sideroblasts in 
bone marrow samples.
• Measuring platelets in circulating blood smears.
• Serum and urine immunofixation.
• Measuring serum IgA, IgM, IGD and IgE con-
centrations.
• Measuring serum b2-microglobulin concentra-
tions.
• Measuring free k and l chains in serum.
Two types of biological material are sent to our 
laboratory for analyses; blood and the bone marrow. 
Depending on the tests, blood should originally be 
sampled into EDTA tubes or be ready for making 
blood smears or preparing bone marrow prepara-
tions. The following tests are done:
• Cytology tests on circulation blood (whole 
blood or smears).
• Cytology tests on bone marrow (two unstained 
bone marrow smears fully labelled with the 
patient’s details and sampling date).
• Measuring alkaline phosphatase activity in 
granulocytes (whole blood/unstained blood 
smears).
• Measuring sideroblasts (2 unstained bone 
marrow smears).
• Cytochemical and cyto-enzymatic tests (4–6 un- 
stained blood or bone marrow samples).
For many years our laboratory has taken 
part in External Quality Control programmes re-
garding microscopic testing on circulating blood 
smears and those obtained from the bone marrow 
(EQA-hem).
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 162 
e-mail: pak@ihit.waw.pl
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Laboratory for Immunophenotyping
Head: Dr Jolanta Wozniak MD
Team: Ms Evelina Franecka MSc, Ms Agnes Krzyw-
dzinska MsC and Dr Ursula Podstawka MD
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 164, +48 22 34 96 166 and 
+48 22 34 96 167 
e-mail: cytometr@ihit.waw.pl
The laboratory performs surface and cyto-
plasmic antigen testing on blood and bone marrow 
cells for patients suffering from diseases of the 
hematopoietic and lymphatic systems by using 
flow-cytometry methods. The analytical instru-
ments are a Becton-Dickinson Cano flow cytometer 
(with 8 colours) based on a protocol described 
either in the literature or in specialist research Pol-
ish or International guidelines as well as in-house 
experience gained from over 20 years. Refer-
ence values are those of cell immunophenotypes 
and the distribution of a subpopulation of leuco-
cytes measured in the blood and bone marrows of 
healthy donors or from regenerated bone marrows 
post-chemotherapy.
Tests for defining the leukocyte immunophe-
notype are multi-colourimetric flow-cytometry 
ones aiming to:
• Determine the phenotype of cancer cells in 
both acute myeloid and acute lymphoblas-
tic leukemias and to establish the aberrant 
phenotypes using ‘empty spaces’ flow cy-
tometry.
• Determining the phenotype of lymphatic sys-
tem cancer cells.
• Cytometric analyses of the bone marrow in 
acute myeloid leukemia (AML) and myelopro-
liferative cancers.
• Treatment monitoring, assessing residual 
disease of the hematopoietic and lymphatic 
systems.
• Assessing sub-population leukocyte degrada-
tion in test material.
• Assessing profiles of basic sub-populations 
of lymphocytes by proportion and absolute 
counts of lymphocytes T, B, NK and T-lym-
phocyte helpers and suppressor cells.
• Defining NK cell sub-populations in Lyme 
disease (CD57+).
• Determining the proportion and life-span of 
CD34+ cells (apheresis products, bone mar-
row).
• The test material comprising of:
• Peripheral blood, bone marrow aspirate taken 
in EDTA.
• Cerebrospinal fluid, BAL, thin-needle biopsied 
material, other bodily fluids and exudates sam-
pled into sterile polypropylene tubes without 
anti-coagulants.
• Lymph nodes — kept in physiological saline 
at 37°C.
Cytogenetic Laboratory
Head: Doctor of Biology Ursula Bany-Laszewicz PhD
Team: Ms Alexandra Bluszcz MSc (Engr), Ms Agnes 
Gajewska MSc and Mr Robert Zietek (Senior technician)
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel; +48 22 34 96 173 and +48 22 34 96 593
e-mail: genetyka@ihit.waw.pl
The laboratory performs cytogenetic tests 
on myeloid and lymphoid neoplasms. Chromo-
some analyses are undertaken by classical band-
ing methods of classical cytogenetics (GTG) and 
fluorescent in situ hybridization (FISH). Karyotyp-
ing is also performed by high resolution banding 
which constitutes the basic post-natal diagnostic 
testing for specific diseases and clinical syndromes 
that arise from chromosomal aberrations. The 
laboratory is equipped with microscopes, with an 
automated facility for seeking metaphases along 
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with a computerised system for registration, data 
calculation and documenting the karyotyping and 
FISH results. The laboratory is fully compliant with 
quality control standards regarding the operation of 
a medical diagnostic laboratory and in the interpre-
tation and authorisation of test results; according to 
Journal of Laws 2006, No. 61, position 435 issued 
by the Polish Minister of Health.
Our testing procedures are also in accordance 
with recommendations and guidelines of specialist 
international scientific groupings and/or with pro-
tocols available from the scientific literature.
Molecular Biology  
Laboratory
Head: Dr Patrick Gorniak MD
Team: Dr Yvonne Solarska MD, Doctor of Biology 
Magdelena Wojtas PhD, Ms Hanna Makuch-Lasica 
MSc, Ms Grazyna Nowak MSc and Ms Ywonne Kania 
(Technician)
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 170, +48 22 34 96 171 and 
+48 22 34 96 594
e-mail: molbiol@ihit.waw.pl
Both qualitative and quantitative measure-
ments are performed in this laboratory using mo-
lecular biology methods which allow to identify 
changes in structural DNA and the expression 
of those genes involved in the pathogenesis of 
hematological diseases. Monitoring minimal 
of residual disease entails using the TaqMan 
technique for RQ-PCR according to interna-
tional protocols laid down in the ‘Europe against 
Cancer’ study as well as ELN guidelines. Our 
laboratory takes part in Polish and European 
projects dedicated to standardising molecular 
biology techniques.
Laboratory for Pathomorphology
Head: Professor of Medicine Monica Prochorec-So-
bieszek MD, DSc
Team: Dr Anna Szumera-Cieckiewicz MD, Dr Olga 
Szymanska-Giemza, Ms Edith Derezinska MSc, Ms Bo- 
zena Rawska MSc, Ms Agatha Bielinska (Engr), Ms Re- 
nata Miasko MSc (Engr) and Ms Monika Okla (Senior 
Technician)
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 456 and +48 22 34 96 457
e-mail: patomorfologia@ihit.waw.pl
The laboratory conducts both research and 
delivers diagnostic services on the pathogenesis 
of diseases arsing from the hematopoietic and 
lymphatic systems. Both complex and multi-disci-
plinary diagnostics and treatment monitoring are 
performed in patients suffering from hematopoietic 
and lymphatic system disease according to national 
and international standards and guidelines put 
forward by scientific societies and working groups 
that include the WHO and ELN.
Our laboratory is rated as a Grade III Reference 
Centre in hematopathology. Performing microscope 
sectioning, staining and mounting cover slips is 
fully automated which permits complete standa-
rdisation of sample preparation procedures to be 
achieved. The laboratory possesses accreditation 
from the Polish Society of Pathologists regarding 
immuno-histological analyses and it regularly takes 
part in external quality control schemes for immu-
no-histochemical staining. Furthermore, it fulfils the 
role of a consultation centre for the whole of Poland 
regarding hematopathology, particularly focused on 
the histopathological and immuno-histochemical di-
agnoses of myeloid and lymphoid malignancies. The 
laboratory also provides courses for clinicians and 
pathologists.
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The full range of tests undertaken at our labo-
ratory are as follows:
• Histopathology on trepanned biopsies with 
1 bone block/preparation.
• Histopathology on surgical material with 
1 bone block/preparation.
• Final assessment by a specialist hemato-
pathologist and issuing the result — trepanned 
biopsy, lymph nodes.
• Final assessment by a specialist hemato-
pathologist and issuing the result — surgi-
cal material.
• A histopathological consultation on received 
specimens.
• Histochemical Giemsa Staining (one step).
• Histochemical Gomori’s staining (one step).
• Histochemical Mucicarmine staining (one 
step).
• Histochemical PAS staining (one step).
• Histochemical Mycobacteria staining (one step).
• Histochemical Congo Red staining (one step).
• Histochemical Perls staining (one step).
• Histochemical Grocott staining (one step)
• Histochemical Alcian-PAS staining (one step).
• Histochemical AZAN trichrome staining 
(one step).
• Immunohistochemical antibody staining 
(one step).
• Manual immunohistochemical antibody stain-
ing (one step).
• One step block slicing and basic H & E staining.
• Paraffin block slicing for genetic testing.
DEPARMENT OF HEMOSTATICS AND METABOLIC DISEASE
Head: Professor of Medicine George Windyga MD, DSc
Professor: Professor of Medicine Ksenia Bykowska 
MD, DSc
Laboratory Diagnosticians: Ms Beatrice Baran MSc, 
Ms Anna Bucko MSc, Dr Agnes Lipniacka MD, Ms Mag - 
dalena Marchewka MSc and Dr Edith Odnoczko MD
Medical Analysts: Ms Evelina Ejchman-Pac MSc
Technicians: Ms Renata Bajszczak (Technician), Ms Ire- 
ne Kaminska (Senior Technician), Ms Anna Moszczy n- 
ska (Technician), Ms Anna Rurka (Senior Technician) 
and Ms Anna Slawinska (Senior Technician)
Laboratory Assistants: Mr Czeslaw Gladczuk, Ms Ca-
the rine Lenart and Ms Christine Ozimek
The department conducts scientific research 
and provides healthcare services as well as teach-
ing and consultation for specialist clinics and other 
clinics both inside and outside the institute dealing 
with hemostasis and porphyria. Laboratory tests 
are undertaken for diagnoses and monitoring pa-
tient treatment of congenital and acquired hemo-
stasis disease: hemophilia A and B, von Willebrand 
disease, and other rare bleeding disorders (eg. fac-
tor VII deficiency, XI, XIII), trombocytopathy, and 
thrombophilia. Besides routine hemostasis testing, 
other specific tests are performed to measure the 
activities of various coagulation factors, antigens 
and von Willebrand factor multimers along with 
detecting and measuring endogenous coagulation 
inhibitors. Platelet function tests are also done 
and measurements of metallo-protease activity 
and its ADAMTS13 inhibitor, together with global 
thrombosis testing: by clot thromboelastometry 
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 157 and +48 695 336 420 
e-mail: jwindyga@ihit.waw.pl
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(ROTEM Delta®) and the TGA Technoclone® test 
of thrombin generation. In addition, the department 
delivers molecular diagnoses of: thrombophilia (de-
tecting Leiden Factor V gene mutations, detecting 
G20210A prothrombin gene mutations, analysing 
the SERPINC1 gene sequence (antithrombin defi-
ciency) and bleeding disorders such as hemophil - 
ia A (detecting inversion mutations [INV1 and 
INV22] and F8 gene sequence analysis), hemophil-
ia B (F9 gene sequence analysis), von Willebrand 
disease (VWF gene sequence analysis) and factor 
XI deficiency (F11 gene sequence analysis).
In Poland, the department is the only diag-
nostics and research centre dealing with porphyria 
diseases insomuch where it provides highly spe-
cialised medical services for all porphyria typing 
and differentiation during the symptomatic disease 
Hemostasis Laboratory
Head: Professor of Medicine Ksenia Bykowska MD, DSc
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 160 and +48 22 34 96 543
The following tests are performed:
1) Biochemical and immuno-enzymatic.
2) Platelet aggregation and function.
3) Genetic testing on peripheral blood samples 
taken in EDTA. DNA is manually isolated by 
an affinity column based method. For identi-
fying chosen point mutations, PCR is used in 
conjunction with restriction fragment length 
polymorphism (PCR-RFLP).
phase. The laboratory tests family members suf-
fering from porphyria to identify asymptomatic 
carriers of the defective gene. It also manages the 
national database covering porphyria patients and 
their families as well as a constantly updated regi-
stry of safe or harmful drugs regarding porphyria.
The departmental laboratories periodically 
undergo external quality control assessment as 
part of the following schemes: The Centre for 
Research Quality Diagnostics Laboratory, ECAT 
Foundation for External Quality Control of Diag-
nostic Assays and Tests with a Focus on Throm-
bosis and Hemostasis along with the European 
Porphyria Network (EPNET) EQAS.
The Department contains a Hemostasis Labo-
ratory, a von-Willebrand Disease Laboratory and 
a Porphyria Laboratory.
Head: Ms Beatrice Baran MSc
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 161 and +48 22 34 96 548
Von Willebrand Laboratory
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DEPARTMENT OF IMMUNOLOGICAL HEMATOLOGY  
AND TRANSFUSION MEDICINE
Head: Professor of Medicine Eva Brojer MD, DSc
Consultant: Professor of Medicine Christine Maslanka 
MD, DSc
Assistant Professors: Doctor of Natural Sciences Cath-
erine Guz MD, DSc, Doctor of Natural Sciences Agnes 
Orzinska PhD and Dr Margaret Uhrynowska MD
Laboratory diagnosticians: Ms Pamela Bartoszewicz 
MSc, Ms Justine Bednarz MSc, Ms Eva Golaszewska 
MSc, Ms Edith Klimczak-Jajor MSc, Ms Patricia Lopacz 
MSc, Ms Hanna Lopienska MSc, Ms Anna Myslinska 
MSc, Ms Maria Nowaczek-Migas MSc, Ms Agnes Ko-
walska MSc, Ms Justine Pastuszek MSc, Ms Anna Kiszlo 
MSc, Ms Monica Pelc-Klopotowska MSc, Ms Hanna 
Address: 5 Chocimska Street, Building B, 00–791 Warsaw 
Tel: +48 22 34 96 663 and +48 605 267 600 
Fax: +48 22 34 96 611 
e-mail: sekimmunologia@ihit.waw.pl
Pyl MSc, Ms Joanna Skulimowska MSc, Justyna Spy-
chalska MSc, Ms Agnes Gierszon MSc, Ms Hedwig 
Sak-Budzisz (Tech Engr), Ms Evelina Sokol MSc and 
Ms Magdalena Pilat MSc
Biologists: Ms Anna Head MSc, Ms Magdalena Krze-
mieniowska MSc, Ms Caterine Kuzior MSc, Ms Mag-
dalena Michalik MSc and Ms Justine Smolarczyk-Wo-
dzinska MSc
Technicians: Ms Eva Dudnikow (Senior technician), 
Ms Beatrice Sierocka (Senior technician), Ms Halina 
Nasiegniewska (Senior technician) and Ms Anna Plizak 
(Technician)
Laboratory assistant: Ms Margaret Tratkiewicz
Secretary’s office: Ms Catherine Stachurska
The department performs diagnostics, research, 
teaching and provides its expertise in immunology, 
hematology and transfusion medicine. Our aims are 
The tasks of the Laboratory include: diagnos-
ing patients suspected of deteriorating or an at-
tack of porphyria, determining porphyria type in 
those already confirmed, diagnosing the family of 
porphyria patients to establish defective gene car-
riers, check-ups on porphyria patients, issuing Sick 
Cards to patients with symptomatic/asymptomatic 
porphyria, keeping a list of safe drugs for treat-
ing porphyria, registering patients in a database, 
research on porphyria, providing teaching/training 
on porphyria to all those interested, collaborating 
with other European centres working on porphyria 
and collaborating with other organisational units 
within the institute regarding research and health-
care services.
Porphyria Laboratory
Head: Dr Agnes Lipniacka MD
Address: 5 Chocimska Street, Building B, 
00–791 Warsaw
Tel: +48 22 34 96 617 and +48 22 34 96 635
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to develop and introduce test methods for assuring 
the safe transfusion of blood and its components, 
performing advanced diagnostics for allo- and au-
to-blood cell antigen immunisation and studies on 
congenital and acquired hemolytic anemia as well as 
chimerism. Other important tasks of the department 
are supervising research on immunology related 
transfusion medicine at organisational units of the 
Public Blood Service. Assessment programmes and 
audits are conducted in Centre for Blood Donation 
and Blood Therapies (CKiK) laboratories and in 
hospitals performing pre-transfusion testing and 
those on foetal-maternal incompatibilities. Accord-
ing to the agreement with the Polish Centre for 
Research and Certification, the department tests in 
vitro diagnostic reagents used for immunology and 
transfusion medicine as well as issuing its expert 
opinion for allowing their use. The department also 
tests scientific equipment/apparatus in these areas.
All department laboratories take part in in-
ternational external Quality Control schemes (UQ 
NEQAS, INSTAND e.V. and ISBT).
Head: Ms Monica Pelc-Klopotowska MSc
Team: Ms Justine Bednarz MSc, Ms Hanna Lopienska 
MSc and Ms Agnes Kowalska MSc
Address: 5 Chocimska Street, 00–791 Warsaw
Tel: +48 22 34 96 669 and +48 22 34 96 651
e-mail: mpelc@ihit.waw.pl
Within immunological-based transfusion medi-
cine, a full range of diagnostic testing is performed 
including consultative-tests in CKiK laboratories, 
whenever self-antibodies arise which need to be 
defined in patients or pregnant women. These tests 
use blood sample bank information on rare antigens 
and serum samples containing antibodies with 
unique specificities (SCARF). Integrated within 
this process is access to international databases 
Research interests of the department are con-
cerned with applying the department’s diagnostics 
and expert capabilities to the immunology of red 
cells, platelets and granulocytes as well as to the 
immunopathology of pregnancy, chimerism testing 
after hematopoietic stem cell transplantation and 
diagnostics of congenital and acquired hemolytic 
anemia and dyserythropoietic anemia.
The department conducts numerous training 
courses and lectures for diagnosticians specialis-
ing in laboratory transfusion medicine, for doctors 
specialising in hematology and clinical transfu-
sion medicine and to gynecologists, obstetricians 
and neonatologists.
The Department consists of: Laboratory of 
Erythrocyte Immunology, Laboratory of Leuko-
cytes and Platelet Immunology, Laboratory for 
Immunopathology of Pregnancy, Laboratory for 
Genetic-Dependent Anemia, Laboratory for Blood 
Grouping and Compatibility and the Laboratory for 
Blood Cell Genetics and Chimerism.
Laboratory of Erythrocyte Immunology
of donors with unique antigens which thus permit 
such blood to become available for transfusion. 
Diagnostic tests are also done in cases of autoim-
mune hemolytic anemia for serological diagnoses of 
weak antigenic types, particularly the ABO and Rh 
systems, together with diagnosing post-transfusion 
hemolytic reactions.
The actual tests that our laboratory performs 
are as follows:
1) Serological tests on anemic auto-/allo-hemolytic 
status post-transfusion of blood components.
2) Serological tests in recipients prior- and post- 
-to hematopoietic stem cells transplantation.
3) Identifying allo-antibodies against erythro-
cytes, including both highly and rarely occur-
ring antigens.
4) Determining phenotypes or weak antigen 
types in recipient or donor blood.
5) Serological features of weak antigen variants.
6) Moreover, the laboratory verifies EC–author-
ised procedures, in which the notified body 
investigates and then certifies that the product 
submitted for medical diagnostic in vitro testing 
meets its intended requirement as reagents to 
be used in immunology and transfusion medi-
cine. For undertaking such tests, the Institute 
was distinguished by the notifying body ie. The 
Polish Centre for Testing and Certification.
206
Hematologia 2016, vol. 7, no. 3
https://journals.viamedica.pl/hematologia
The laboratory investigates, assesses and issues 
opinions on automated and semi-automated systems 
for blood group testing, for detecting immune system 
antibodies and for measuring the anti-D antibody 
in the therapeutic anti-D immunoglobulin product 
(Anti-Gamma D 50 and Anti-Gamma D 150). The Na-
tional Programme for External Quality Assessment 
is also managed and run by our laboratory.
Head: Ms Patricia Lopacz MSc
Team: Ms Anna Glowka MSc, Ms Agnes Gierszon MSc, 
Ms Hedwig Sak-Budzisz (Engr, Senior Technician), Ms 
Halina Nasiegniewska, Ms Beatrice Sierocka (Senior 
technician), Ms Evelina Sokol MSc and Ms Magdalena 
Pilate MSc
Address: 5 Chocimska Street, 00–791 Warsaw
Tel: +48 22 34 96 947, +48 22 34 96 615 and 
+48 22 34 96 675
e-mail: plopacz@ihit.waw.pl
Head: Dr Margaret Uhrynowska MD
Team: Ms Magdalena Michalik MSc, Ms Pamela Bar-
toszewicz MSc and Ms Anna Plizak
Address: 5 Chocimska Street, 00–791 Warsaw
Tel: +48 22 34 96 668 and +48 22 34 96 671
e-mail: muhrynowska@ihit.waw.pl
The laboratory performs serological screening 
and diagnostics for all pregnant women (RhD-ne-
gative and RhD-positive) to establish whether ma-
ternal-foetal compatibility exists or not regarding 
erythrocytes. Such tests should be carried out in 
duplicate in all pregnant women at up to 10 weeks 
Laboratory of Leukocytes and Platelet Immunology
• Maternal-foetal incompatibilities of platelet 
antigens.
• Auto/allo- immunological thrombocytopenia.
• Heparin-dependent thrombocytopenia.
• Pseudotrombocytopenia.
• Platelet membrane glycoprotein deficiency 
(Glanzmann’s thrombasthenia, the team Ber-
nard-Soulier syndrome).
• Phenotyping the HPA-1 antigen (risk assess-
ment on maternal-foetal antigen incompa-
tibility with non-HPA-1a);
• Immuno-complications in transfused plate-
let concentrates.
• Anti-HLA class I and II antibodies (comple-
ment binding and non-binding capacity).
• Selection of platelet donors according to leuko-
cyte-platelet compatibility for immunised pa-
tients.
• Primary and secondary granulocytopenia.
• Non-hemolytic contraindications post-transfu-
sion including transfusion-related acute lung 
injury (TRALI).
• Reticulocyte blood count.
In addition, the laboratory provides consul-
tation for all tests performed and takes part in 
organising external quality control schemes for 
CKiK as well as undertaking scientific research.
Laboratory for Immunopathology of Pregnancy
This is the only laboratory in Poland that 
performs highly specialised diagnostic tests as 
follows:
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Laboratory for Genetic-Dependent Anemia
Head: Dr Margaret Uhrynowska MD
Team: Ms Eva Golaszewska MSc, Ms Edith Klimczak-Ja-
jor MSc, Ms Anna Myslinska MSc, Ms Hanna Pyl MSc 
and Ms Justine Spychalska MSc
Address: 5 Chocimska Street, 00–791 Warszawa
Tel: +48 22 34 96 668, +48 22 34 96 677, +48 22 34 96 658, 
+48 22 34 96 673 and +48 22 34 96 679
e-mail: muhrynowska@ihit.waw.pl
The Laboratory carries out unique diagnos-
tic tests on hereditary spherocytosis, hemoglo-
binopthies, thalassemia, paroxysmal nocturnal 
hemoglobinuria and congenital dyserythropoietic 
anemia. Testing is also performed for maternal-fe-
tal transplacental leakage and on material derived 
from cordocentesis by flow cytometry.
Laboratory for Blood Grouping and Compatibility
Head: Ms Beatrice Wojciechowska MSc
Team: Ms Catherine Kuzior MSc, Ms Justine Pastuszek 
MSc and Ms Eva Dudnikow (Senior technician)
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 383, +48 22 34 96 404 and 
+48 22 34 96 570
e-mail: bwojciechowska@ihit.waw.pl
The laboratory carries out all pre-transfusion 
tests, that includes blood typing, histocompati-
bility tests, matching blood for recipients for 
allo-antibodies and/or auto-antibodies, detecting 
and identifying immune antibodies and in deter-
ming erythrocyte phenotype.
and at 27–32 weeks as well as 21–26 weeks in 
those RhD-negative. They are vital for diagnos-
ing incompatibilities and for selecting which blood 
type should be transfused to the mother/child if 
such a need should arise. Whenever antibodies 
are detected to many antigens or those universally 
present in the population, then their specificities to 
transfused blood is required with the aim of finding 
a suitable donor. Upon detecting such antibodies, 
then the CKiK is notified so that a particular blood 
can be secured.
Collaborative work is undertaken with the 
Laboratory for Blood Cell Genetics and Chimerism 
for non-invasive genotyping of foetal antigens so 
as to exclude any risk of hemolytic disease, when 
there are no foetal antigens present to which the 
mother’s antibodies can react with. Our laboratory 
also collaborates with the Laboratory of Eryth-
rocyte Immunology where antibodies are tested 
against universally occurring antigens.
Screening is also conducted for HPA-1a plate-
let antigens which play the dominant role in ma-
ternal-foetal incompatibilities regarding platelets.
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Laboratory for Blood Cell Genetics and Chimerism
Head: Doctor of Biology Catherine Guz PhD
Team: Ms Agnes Orzinska PhD, Ms Justine Smolarczyk- 
-Wodzynska MSc, Ms Magdalena Krzemieniowska MSc, 
Ms Anna Kiszlo MSc, Ms Joanna Skulimowska MSc and 
Ms Sylvia Purchla-Szepiola MSc
Address: 5 Chocimska Street, Building B, 00–957 Warsaw
Tel: +48 22 34 96 630, +48 22 34 96 637 and 
+48 22 34 96 649
e-mail: kguz@ihit.waw.pl
Highly specialised tests, unique in Poland, are 
undertaken in this laboratory for genotyping blood 
cell antigens and chimerism testing, post-trans-
plantation. The former concerns antigens from 
platelets, erythrocytes and granulocytes and are 
conducted in cases of maternal/foetal incompat-
ibilities or in assessing auto-/allo-immunisation 
in patients. When considering genetic testing of 
erythrocyte antigens, the importance of non-in-
vasive prenatal molecular diagnostics should be 
especially stressed for antigens RhD, c, E, and F 
from the foetus as detected in the plasma of preg-
nant woman in the foetal DNA. The actual tests 
carried out in our laboratory are:
1) Genetic diagnostics on maternal-foetal in-
compatibilities regarding platelet antigens 
granulocytes and erythrocytes:
• Foetal RHD gene genotyping from ma-
ternal blood is performed for qualifying 
those suited for immuno-prophylaxis 
during pregnancy. Non-invasive foetal 
RHD gene genotyping is done for qualify-
ing whenever RhD immuno-prophylaxis 
is required in cases of maternal-foetal 
incompatibility in RhD negative women 
between 12th and 27th week of pregnancy 
(ideally between 21st and 26th weeks) and 
whenever immune antibodies anti-D are 
lacking in the 12th and/or 20th weeks of 
pregnancy. In cases when the foetus is 
RHD-positive, the ultimate criterion gov-
erning whether immunoglobulin anti-D is 
given in the 29th–30th week of pregnancy 
is if anti-D antibodies are absent — and 
also in the 28th week (recommended time 
of administration).
• RHD genotyping and/or of RHCE*c*C* 
E foetal alleles is undertaken from the 
mother’s blood using anti-D, anti-C, an-
ti-C or anti-E antibodies. Non-invasive 
foetal diagnostics using maternal blood 
containing antibodies to red blood cells 
is recommended in the second trimester 
(from the 15th–16th weeks of pregnancy). 
This avoids any invasive methods for de-
termining foetal blood type with negative 
genotyping outcome.
• The genotype of foetal antigens in am-
niotic fluid is determined. Tests are 
recommended for those women with 
antibodies present and are undergoing 
amniocentesis, including those with other 
clinical indications or through a less inva-
sive method of obtaining foetal material 
than cordocentesis.
• Determining antigenic incompatibilities 
which are based on maternal and paternal 
genotyping or that of the mother and fe-
tus/newborn. Such tests are performed 
on platelet antigens and granulocytes, 
whenever fetal/newborn-maternal al-
lo-immune thrombocytopenia or granu-
locytopenia in newborns are suspected, 
as methods for establishing antibody spe-
cificities through detecting/excluding the 
antigenic incompatibilities of parents or 
those of the mother and child in the most 
significant HPA/HNA systems (human 
platelet/ human neutrophil antigens).
2) Genotyping erythrocyte antigens after al-
lo-HSCT/allo-transfusion thereby facilitating 
the measurement of antibodies and for identi-
fying allo-antibodies in patients with:
• Whenever any difficulties arising from 
the erythrocyte phenotype are found after 
multi-transfusions or allo-HSCT (aris-
ing < 3 months).
• In the presence of auto-/allo-antibodies 
found amongst those suffering from au-
toimmune hemolytic anemia.
• Suspected antibodies to universal/rare 
antigens are found.
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• Anomalous serotyping results for D and 
ABO variants.
3) Genotyping HPAs. Tests that enable the spe-
cificities of anti-HPA antibodies to be deter-
mined in patients with thrombocytopenia 
dyscrasia, immunity to transfused platelets 
or with thrombocytopenia post-allo-HSCT. 
Identifying the HPA genotype also enables 
KKP-compatible HPA donors to be found.
4) Genotyping HNAs. Tests that facilitate the 
identification of anti-HNA antibodies in pa-
tients where the TRALI syndrome is suspect-
ed, those with neutropenia post-allo-HSCT 
and organ transplant rejection patients (includ-
ing the kidneys regarding HNA-3 antigens).
5) Genotyping HPAs, HNAs and selected eryth-
rocyte blood types for blood donors. This offer 
is directed to the CKiK so that a blood donor 
registry can be established for HPA, HNA and 
other chosen erythrocyte antigens.
6) Investigating chimerism post-allo-HSCT: de-
termining the STR marker genotype in donors 
and recipients before HSC transplantation and 
measuring the genotype proportions in donors 
(proportion of donor STR markers vs recipient 
STR markers) in the blood or bone marrow of 
recipients, post-allo-HSCT.
7) Measuring genetic mutations in hemoglobi-
nopathies in order to establish the genetic 
basis of a and b-thalassemia.
DEPARTMENT OF IMMUNOGENETICS
Head: Professor of Medicine Jack Nowak MD, DSc
Deputy: Dr Ursula Szlendak MD
Laboratory diagnosticians: Ms Joanna Dziopa MSc, 
Mr Slawomir Gwozdowicz MSc, Ms Elizabeth Graczyk-Pol 
MSc, Ms Agnes Malinowska MSc, Ms Anna Marosz- 
-Rudnicka MSc, Ms Renata Mika-Witkowska MSc, 
Ms Klaudia Nestorowicz MSc, Ms Daria Pawliczak MSc, 
Ms Martha Rogatko-Koros MSc, Ms Agnes Witkowska 
MSc and Ms Emily Wojciechowska MSc
Secretary’s office: Ms Agnes Gawron
The department provides healthcare and sci-
entific services on immunogenetic typing of donors 
and recipients regarding HSC transplantation as 
well as providing training and consultations in this 
field. Within such procedures, the department man-
ages immunogenetic selection of unrelated, family 
and haploidentical HSC donors for allogeneic trans-
plantation. The department searches for donors in 
country-based and international registries where it 
sets the strategy for choosing a family or unrelated 
donors and performs HLA and KIR genotyping 
together with providing advice on optimal immu-
nogenetic selection of family or unrelated donors.
Scientific activities are focused on preparing 
immunogenetic standards for selecting donors, 
genetic testing methodology and population genetic 
testing regarding HLA during and at the start of 
illness. Another important area of investigation 
are on the pathogenesis of paroxysmal noctur-
nal hemoglobinuria.
The Department conducts both under and 
post-graduate training on HLA study methodolo-
gies and co-organises internships specialising in 
laboratory immunological medicine and trans-
plantology. Training on an individual basis are 
also provided to those specialising in hematology, 
Address: 5 Chocimska Street, 00–791 Warszawa 
Tel: +48 22 34 96 648 and +48 602 290 529 
Fax: +48 22 34 96 606 
e-mail: szpik@ihit.waw.pl
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transplantology, transfusion medicine, analytical 
medicine, laboratory hematology medicine, im-
munological medicine and medical genetics.
The Department comprises of a Laboratory 
of Tissue Histocompatibility and a Laboratory for 
Hematopoietic Cell Donor Selection.
Laboratory of Tissue Histocompatibility
Head: Ms Renata Mika-Witkowska MSc
Address: 5 Chocimska Street, 00–957 Warszawa
Tel: +48 22 34 96 672 and +48 22 34 96 659
Antigen tests performed in the Laboratory 
are as follows: HLA and KIR histocompatibility 
antigens by PCR-SSP (sequence specific prim-
ers) and PCR-SSO Luminex® (sequence specific 
oligonucleotide probes). The test material is blood 
sampled in EDTA; in 4 or 10 ml volumes.
Laboratory for Hematopoietic Cell Donor Selection
Head: Ms Claudia Nestorowicz MSc
Address: 5 Chocimska Street, 00–957 Warszawa
Tel: +48 22 34 96 623
Duties of the laboratory are in selecting unrela-
ted HSC donors for allogeneic transplantation. Seek-
ing for such donors is performed in country-based 
or international registries. In cases where histocom-
patibility is incomplete, the laboratory will propose 
an optimal unrelated candidate that is partially 
histocompatible or a haploidentical one from the 
family. To fulfil such aims the laboratory performs 
additional tests such as KIR or HLA-DPB1 geno-
typing. These tests may require immunogenetic 
expertise in choosing an optimal HSC donor. Tests 
carried out by the laboratory are as follows:
1) KIR genotyping in HSC donors and transplant 
recipients as well as expertise for measuring 
KIR B haplotype content and for predicting 
donor NK cell licensing under new HLA con-
ditions of the recipient. The test can be used 
in HSC transplant cases where the donor 
is partially matched in terms of HLA class I 
or haploidentical. The test permits precise 
assessment of a wide variety of KIR B haplo-
types and functional HLA-KIR receptor-ligand 
pairs in donors, along with changes in these 
pairs which occur in the recipient, post-trans-
plantation. The test also allows a donor to be 
selected with a higher anti-cancer potential of 
the NK cells, not only through determining the 
KIR B haplotype content, but above all else 
by predicting changes in the donor NK cell 
licensing within the new HLA conditions in 
the recipient. In order to pick the best donor, 
then as aforementioned, expertise is needed. 
The aim of the test and expert opinion thus 
improves the chances of eradicating cancers in 
the recipients treated by HSC transplantation.
2) Genotyping HLA DPB1 with high resolution. 
Introducing additional typing of the HLA 
(DPB1) locus enables the histocompatibility of 
the donor-recipient pair to be so established. 
This becomes especially important when 
donors are only partially histocompatible 
regarding HLA or being haploidentical. In 
such cases of HSC transplantation, the pres-
ence of anti-HLA antibodies are significant 
(anti-HLA-DP or multispecific). Choosing 
a donor in respect of HLA-DPB1 can prevent 
a transplant rejection in those recipients im-
munised.
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DEPARTMENT OF VIROLOGY
Head: Professor of Medicine Peter Grabarczyk MD, 
DSc
Laboratory diagnosticians: Mr Paul Brylka MSc, Ms Ale - 
xandra Kalinska MSc , Ms Anette Kopacz MSc, Ms Do- 
rothy Kubicka-Russel MSc, Mr Gregory Liszewski MSc, 
Ms Eva Nocen MSc, Ms Anna Potepa MSc, Ms Joanna 
Sierzega MSc, Ms Eva Sulkowska MSc, Ms Justine 
Sledz and Ms Pauline Zwolinska MSc
Biologists: Ms Anna Chrzanowska
Laboratory assistant: Ms Sophie Grzywacz
Secretary’s office: Ms Catherine Tkachuk
The Department of Virology undertakes re-
search studies and provides healthcare services, 
training and consultation in the field of medi-
cal virology; particularly in the diagnosis and 
epidemiology of those viruses vital for ensuring 
blood transfusion safety, including hepatitis virus 
A (HAV), B (HBV), hepatitis C virus (HCV) virus, 
acquired immune deficiency syndrome (HIV-1/2), 
parvovirus B19 (B19V), cytomegalovirus (CMV), 
Epstein-Barr virus (EBV) and BK virus (BKV). 
Infections also diagnosed are human leukemia vi-
rus-induced T-cell (HTLV I / II) as well as non-viral 
ones such as syphilis and toxoplasmosis.
Verification and complementing tests are 
performed for all CKiK centres and the depart-
Address: 5 Chocimska Street, 00–957 Warszawa 
Tel: +48 22 34 96 640 
Fax: +48 22 34 96 603 
e-mail: zakladwirusologii@ihit.waw.pl
ment acts as a reference centre on blood-borne 
viral infections. Tests are also conducted on newly 
emerging infectious agents, for instance hepatitis E 
(HEV) and the West Nile virus (WNV).
Research is focused on diagnostics that include 
improving methods for detection/verification/in-
fection diagnosis in donors as well as analysing 
epidemiological data and studying blood-borne viral 
polymorphism. These studies include introducing 
and improving detection methods, monitoring algo-
rithms for virally infected patients, distinguishing 
between latent and active viral forms and assess-
ing the efficacy of anti-viral therapy. Research is 
also undertaken on the epidemiology of molecular 
virology which include identifying ‘escape mutants’ 
and their modes of transmission.
The Department conducts lectures as part of 
courses for laboratory diagnosticians specialising 
in transfusion medicine as well as for physicians 
specialising in clinical and hematological transfu-
sion medicine. Also provided are teaching courses 
and training for CKiK directors and consultants at 
regional (Voivodeship) levels in transfusion medicine.
The Department comprises of a Laboratory for 
Verification Testing, Clinical Virology Laboratory 
and a Laboratory for Quality Control and Analysis.
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Laboratory for Verification Testing
Clinical Virology Laboratory
Head: Ms Eva Sulkowska MSc
Team: Ms Anna Chrzanowska MSc, Ms Eva Nocen MSc 
and Ms Justine Sledz MSc
Address: 5 Chocimska Street, 00–957 Warsaw
Tel: +48 22 34 96 662
Fax: +48 22 34 96 603
e-mail: esulkowska@ihit.waw.pl
Head: Ms Alexandra Kalinska MSc
Team: Ms Paula Brylka MSc, Ms Anette Klimczak-Plich-
ta MSc, Ms Anna Potępa MSc, Ms Joanna Sierzega MSc 
and Ms Pauline Zwolinska MSc
Address: 5 Chocimska Street, 00–957 Warsaw
Tel: +48 22 34 96 644
Fax: +48 22 34 96 603
e-mail: akalinska@ihit.waw.pl
Laboratory for Quality Control and Analysis
Head: Ms Anette Kopacz MSc
Team: Ms Dorothy Kubicka-Russel MSc and Mr Gregory 
Liszewski MSc
Address: 5 Chocimska Street, 00–957 Warsaw
Tel: +48 22 34 96 646
Fax: +48 22 34 96 603
e-mail: akopacz@ihit.waw.pl
The laboratory evaluates instrumentation, 
methods and tests for infectious agents regard-
ing monitoring studies for blood donor suitability. 
Epidemiological testing is performed on detection 
rates of viral infections, (HBV, HCV and HIV), in 
donors of blood and its components. Virological 
tests are also carried out on those donors and pa-
tients in whom infection has been detected, where 
amongst other things, the infection phase and the 
prevalence of polymorphisms in the aforemen-
tioned viruses is determined for Poland.
Sample panels are prepared for the purposes 
of validation and quality control testing regarding 
introduced methods to measure transmitted infec-
tious agents in blood taken from CKiK units. The 
laboratory analyses and assesses the panel test 
results so obtained.
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DEPARTMENT OF RADIOLOGY
Head: Professor of Medicine Andrew Cieszanowski 
MD, DSc
Doctors: Dr Andrew Juszynski MD, Dr Jack Proniewski, 
Dr George Wojtowicz and Dr Janina Zulewska
Technicians: Mr Alexander Cieslak (Senior technician), 
Ms Margaret Czajkowska (Senior technician), Ms Ga-
briella Michalowska (Senior technician). Ms Christine 
Wisniewska (Senior technician) and Mr Camille Wegr-
zycki (Technician)
Secretary’s office: Ms Elizabeth Dlutek
Registration: Mr Andrew Markowicz
Nurses: Ms Hedwig Siwiec and Ms Hanna Ziemczyk
The department delivers healthcare services 
and performs scientific studies in the radiological 
fields of diagnostics and surgery, where it also 
provides teaching/training and consultation within 
these areas. It has a diverse, modern infrastructure 
and equipment thereby allowing radiology diagnos-
tics and research to be conducted. All equipment 
is digitalised and fully computerised so enabling 
the electronic archiving of all testing performed.
Diagnostic radiological imaging techniques, 
computed tomography (CT) and ultrasonography 
(USG; ultrasound) is carried out together with CT 
angiography, venography and Doppler ultrasound.
The Department consists of a Laboratory for 
General Radiology and Ultrasound and a Computer 
Tomography Unit.
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 450 
e-mail: edlutek@ihit.waw.pl
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Head: Professor of Medicine Przemyslaw Juszczynski 
MD, DSc
Deputy Head: Doctor of Biology Matthew Szydlowski 
PhD
Senior Lecturers: Doctor of Biology Emily Bialopiotro-
wicz PhD, Dr Patrick Gorniak MD, Doctor of Biology Eva 
Jablonska PhD and Dr Anna Polak MD
Biologists: Ms Monica Noyszewska-Kania MSc and Ms 
Caroline Piechna MSc
Alumni: Dr Thomas Sewastianik and Dr Przemyslaw 
Kiliszek
Secretary’s office: Ms Monika Milczarek-Starling MSc
The Department of Experimental Hematology 
arose in 2016 when the Laboratory of Hematology at 
the Department of Experimental Diagnostic Hema-
tology became transformed into an independent 
organisational unit. The appointed tasks and staff of 
this new department constitute an enlargement and 
continuation of those started in 2011. Creating this 
new unit and its staff recruitment were made possi-
ble by the institute’s investment funding and grants 
obtained in 2011 from the Foundation for Polish 
Science (FNP) as well as the National Science 
Centre (NCN).
From its inception, the department has under-
taken research into the pathogenesis of myeloid 
and lymphoid malignancies. In particular taking 
into account the molecular heterogeneity of B-cell 
lymphomas and their growth determinants along 
with identifying rational targets for therapy. The 
main thrust of these studies are on the molecular 
mechanisms of transmitting B-cell receptor signals 
in diffuse large B-cell lymphomas and in identify-
ing optimal therapeutic strategies leading to signal 
blocking and arresting its anti-apoptotic action.
Another area of research concerns the molecu-
lar mechanisms underlying the oncogenic activity 
of PIM kinases and defining thereby potential 
therapeutic targets for their inhibitors. The labora-
tory also conducts research on cellular resistance 
in acute lymphoblastic leukaemia to chemothera-
peutics and targeted pharmacological methods 
that sensitise blasts to conventional cytotoxic 
drugs. Study outcomes have been published in jour-
nals of high repute and have made a considerable 
impact to the field as demonstrated by numerous 
citations and both national and international awards 
for our team members.
The laboratory makes use of a wide spectrum 
of techniques in molecular biology, biochemistry 
and bioinformatics for its research that is focused on 
in-depth functional verification posed by scientific 
questions and hypotheses. In this work our depart-
ment closely collaborates with the Haematology 
Clinic and the Department of Diagnostic Haemato-
logy. A key resource in the infrastructure dedicated 
to research is the Laboratory for Digital Pathology 
(‘Cyfralab’); http://www.cyfrowelaboratorium.ihit.
waw.pl. This constitutes an integrated system of 
research equipment/instrumentation that enables, 
inter alia, the construction of multiblock automated 
staining, the acquisition and analysis of digital ima-
ges and micro-laser dissection; this infrastructure 
being complemented by an IT system that inte-
grates each functional module as well as including 
a digital library of images and a tissue bank of fresh 
and fixed samples.
Most of the departmental research is under-
taken thanks to grant funding from the FNP, the 
NCN and the National Research and Development 
Centre (NCBiR). As of 2015, the departmental 
team conducts research under the Strategmed 
I and II projects designed to develop and imple-
ment innovative targeted therapies in myeloid and 
lymphoid malignancies.
Department of Experimental Hematology
Address: 14 Indira Gandhi Street, 02–776 Warsaw 
Tel: +48 22 34 96 517, +48 22 34 96 518 and 
+48 22 34 96 305 
e-mail: pjuszczynski@ihit.waw.pl
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The Department consists of the following 
laboratories: Lymphoid Malignancies, Myeloid 
Laboratory for Cancer Immunology
Head: Mr Matthew Szydlowski PhD
Team: Dr Anna Polak
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 517, +48 22 34 96 518 and 
+48 22 34 96 305
e-mail: mszydlowski@ihit.waw.pl
Head: Ms Emily Bialopiotrowicz PhD
Team: Monica Noyszewska-Kania MSc
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 517, +48 22 34 96 518 and 
+48 22 34 96 305
e-mail: ejablonska@ihit.waw.pl
The laboratory develops new strategies for 
immunotherapy in myeloid and lymphoid neo-
plasms. These studies are carried out within a wide 
multi-centre collaboration of the Strategmed pro-
gram. The laboratory also works with other institute 
laboratories, the Haematology Clinic and the Depart-
ment of Diagnostic Haematology regarding immuno-
logical techniques used for studies on tumours of the 
hematopoietic and lymphatic systems.
Malignancies, Cancer Immunology and Genetics 
and Computational Biology.
Laboratory for Lymphoid Malignancies
The mechanisms of B-cell tumour pathoge-
nesis and identifying their therapeutic targets form 
the bulk of this laboratory’s work. Studies are fo-
cused firstly on the mechanisms of B-cell receptor 
signal transmission and its effectors and secondly 
on the role of PIM kinases in such tumours. Further 
research is also performed on the mechanisms of 
drug resistance in acute lymphoblastic leukaemia 
and profiling the characteristics of clonogenic 
cell populations.
Laboratory for Myeloid Malignancies
Address: 14 Indira Gandhi Street, 02–776 Warszawa
Tel: +48 22 34 96 517, +48 22 34 96 518 and 
+48 22 34 96 305
e-mail: ebialopiotrowicz@ihit.waw.pl
The laboratory seeks for new epigenetic and 
metabolic mechanisms occurring in tumours of the 
hematopoietic system, which can be targeted by in-
hibitors and thereby potentially constituting a novel 
therapeutic strategy. In addition, the mechanisms 
for determining the potential of self-renewal in 
leukemic stem cells are investigated.
Head: Ms Eva Jablonska PhD
Team: Ms Caroline Piechna MSc
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Laboratory for Genetics and Computational Biology
Address: 14 Indira Gandhi Street, 02–776 Warsaw
Tel: +48 22 34 96 517, +48 22 34 96 518 and 
+48 22 34 96 305
e-mail: pgorniak@ihit.waw.pl
This laboratory collaborates with other insti-
tute laboratories concerning bioinformatic tech-
niques and large scale study analyses required for 
ongoing research projects. It also provides research 
facilities for developing and validating new diagnos-
tic tests that use techniques based on genetics and 
molecular biology.Head: Mr Patrick Gorniak PhD
